Datasets:

nickmuchi

/

trade-the-event-finance

like 7

EXORCIST BISHOP JAMES LONG, PSYCHIC AND WHITE WITCH PATTI NEGRI, VAMPIRE EXPERT MICHELLE BELANGER, PROLIFIC HISTORIAN AND HALLOWEEN EXPERT LISA MORTON, TAROT EXPERT SASHA GRAHAM, ENERGY HEALER SATISH DHOLAKIA, PSYCHIATRIST DR WAGUIH ISHAK AND HOMEOWNER AND CARDIOLOGIST/PROFESSOR DR ERNST VON SCHWARZ AMONG PARANORMAL EXPERTS WHO WILL LEAD WEEKEND-LONG HALLOWEEN CELEBRATION$25 TICKET FOR PAY-PER-VIEW EVENT ALLOWS THREE DAYS OF 24-HOUR VIRTUAL ACCESS TO HOUSE AND ALL EVENTSTICKETS ON SALE NOWLOS ANGELES, Oct. 23, 2020 /PRNewswire/ -- With this week's announcement that The Infamous American Horror Story Murder House will open to the public for the first time ever, homeowners Dr Ernst von Schwarz and his wife Angela Oakenfold have now revealed the list of participants for the three-day, 24-hour first-ever live stream event from the notorious historical Los Angeles monument. Watch a preview of the livestream here. (PRNewsfoto/The Murder House) Kicking off at dusk Thursday, October 29 and closing out at sunset Sunday, November 1, The Murder House livestream event will feature 15 cameras set up throughout the 10,000-square foot home streaming live throughout the entire weekend. Beyond The Murder House live stream, viewers will see daily programming (details below). While the live stream is open to all via the ticketed event, The Murder House will open its doors to a few lucky ticket holders. Six fortunate (or unfortunate)--two per each of the three nights--Murder House fans in the terrifying basement all while being live streamed to the world (while a doctor monitors their vital signs and psychological condition). An initial outline of the weekend's events is as follows: The first-ever paranormal investigation will be carried out by Exorcist Bishop James Long, who has appeared on "Ghost Adventures," "The Possessed," "Gates Of Hell," "Exorcism Live!" and "Portals To Hell" Famous psychic and white witch Patti Negri from "Ghost Adventures" will lead the houses first-ever seance Michelle Belanger, vampire expert and acclaimed author who has been seen on "Paranormal State," "Portals To Hell " and "The Real Vampire Files" will delve into the haunting world of the occult Prolific historian and Halloween expert Lisa Morton will take us on an exploration of the history & traditions of Halloween Tarot expert Sasha Graham will explain the world of tarot and one lucky ticket holder will get a virtual reading live on air Energy healer Satish Dholakia will give advice on how to protect yourself from negative energies and unwanted evil entities Psychiatrist Dr Waguih Ishak will discuss the addictive nature of horror and the pathology of fear Homeowner and cardiologist and Professor Dr Ernst von Schwarz will delve into the history of medieval torture techniques Tickets are on sale now at www.themurderhouse.com. In addition, a commemorative t-shirt for the event will be on sale on the website. A portion of proceeds from the event will be donated to the Baby2Baby charity.WebsiteInstagramTwitterTikTokSOURCE The Murder House Related Links http://www.themurderhouse.com

"AMERICAN HORROR STORY" MURDER HOUSE OPENS TO PUBLIC FOR FIRST TIME EVER FOR PARANORMAL HALLOWEEN WEEKEND LIVE STREAM USA - English USA - English Latin America - espaol Brazil - Portugus Espaa - espaol

DENVER, Aug. 27, 2020 /PRNewswire/ --ParkMobile, the leading provider of smart parking and mobility solutions in the U.S.,announced today the launch of service on the Auraria Campus in Denver, Colorado. Effective September 1, 2020, the previous mobile parking app, Passport, will no longer be available. The ParkMobile app will be the only parking payment app available on campus. Students, faculty, staff, and visitors will be able to use the ParkMobile app for touchless parking payments for over 4,100 parking spaces available on campus. Effective September 1, 2020, the ParkMobile app will be the only parking payment app available on Auraria Campus in Denver, CO. Students, faculty, staff, and visitors will be able to use the ParkMobile app for touchless parking payments for over 4,100 parking spaces available on campus. To pay for parking with the ParkMobile app, a user enters the zone number posted on the stickers and signs around parking space. The user then selects the amount of time needed and touches the Start Parking button to begin the session. ParkMobile is the #1 parking app in the U.S. with over 19 million users and is available for both iPhone and Android devices. To pay for parking with the ParkMobile app, a user enters the zone number posted on the stickers and signs around parking space. The user then selects the amount of time needed and touches the "Start Parking" button to begin the session. The user can also extend the time of the parking session on their mobile device without having to go back to the meter. ParkMobile offers all the same features and functionality as Passport app but provides a better user experience and 24/7/365 customer support. The ParkMobile app is also available in many more locations in the Colorado and across the country. The launch of ParkMobile on the Auraria Campus expands the company's footprint in Colorado. There are currently over 700,000 users of the app in the state with availability in Denver, Boulder, Winter Park, Telluride, Manitou Springs, Steamboat Springs, and Colorado Springs. Additionally, the app can be used at the University of Denver, and the University of Colorado Boulder and Colorado Springs campuses. Beyond Colorado, the app can be used to pay for parking in over 400 cities across the United States. "We're always working to improve the parking experience for the Auraria Campus community," said Lena Price, Director or Parking & Transportation Services. "After much research, we found that ParkMobile provides a better user experience and already has a large base of users in downtown Denver. We anticipate that this will be an easy transition for the Auraria Campus community.""We want to welcome the Auraria Campus to our network in Colorado," says Jon Ziglar, CEO of ParkMobile. "We have thousands of users in the immediate area who will now have an easier way to pay for parking when they visit the campus.About ParkMobile ParkMobile, LLC is the leading provider of smart parking and mobility solutions in North America, using a contactless approach to help millions of people easily find, reserve, and pay for parking on their mobile device. The company's technology is used in thousands of locations across the country, including eight of the top 10 cities as well as college campuses, airports, and stadiums. People can use ParkMobile solutions to quickly pay for on-street and off-street parking without having to use a meter or kiosk. Additionally, ParkMobile offers parking reservations at stadium venues for concerts and sporting events. Reservations are also available in metro area garages, allowing people to drive into the city without having to worry about finding parking. ParkMobile has been named to the Inc. 5000, Deloitte Fast 500, Smart Cities Connect "Smart 50," and the Atlanta Journal Constitution's Top Workplaces. Additionally, the company won the 2020 Stevie Awards for Achievement in Product Innovation and the 2019 Stevie Awards for Most Innovative Tech Company and Best Travel App. For more information, visit ParkMobile.io or @ParkMobile on Twitter.ParkMobile Contact:Jeff Perkins, CMO, [emailprotected]Auraria Campus Contact:Lena Price, Director, Parking & Transportation Services, [emailprotected]SOURCE ParkMobile Related Links https://parkmobile.io/

Auraria Campus Partners with ParkMobile to Offer Contactless Payments on Denver Campus ParkMobile replaces the Passport app for campus parking

DUBLIN, Nov. 20, 2020 /PRNewswire/ -- The "Dispensing Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 9th edition of this report. The 290-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Global Dispensing Systems Market to Reach $47.5 Billion by 2027Amid the COVID-19 crisis, the global market for Dispensing Systems estimated at US$37.1 Billion in the year 2020, is projected to reach a revised size of US$47.5 Billion by 2027, growing at a CAGR of 3.6% over the analysis period 2020-2027. Robotic Dispensing System, one of the segments analyzed in the report, is projected to record a 4.1% CAGR and reach US$23 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Semi-Robotic Dispensing System segment is readjusted to a revised 3.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $10 Billion, While China is Forecast to Grow at 6.6% CAGRThe Dispensing Systems market in the U.S. is estimated at US$10 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$10 Billion by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1% and 2.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.Manual Dispensing System Segment to Record 1.9% CAGRIn the global Manual Dispensing System segment, USA, Canada, Japan, China and Europe will drive the 1.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.5 Billion in the year 2020 will reach a projected size of US$6.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.7 Billion by the year 2027, while Latin America will expand at a 2.6% CAGR through the analysis period. Competitors identified in this market include, among others: ABB Group Buehler Dema Engineering Co. Dover Corporation Durr AG Dymax Corporation Eisenmann SE Emc2, Inc. Ems-Eftec (EFTEC AG) Esys Automation Exact Dispensing Systems Fisnar Inc. Graco, Inc. IPR - Intelligent Peripherals for Robots GmbH Jensen Global Dispensing Kleerblue Solutions Nordson Corporation SCA Schucker GmbH & Co Oficina Comercial Techcon Systems, Inc. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Dispensing Systems Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of COVID-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 38 For more information about this report visit https://www.researchandmarkets.com/r/oyzugk Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

$37.1 Billion Worldwide Dispensing Systems Industry to 2027 - Impact of COVID-19 on the Market

NEW YORK, June 25, 2020 /PRNewswire/ --CBAM, an alternative investment management firm, has announced that Neil Phillips has joined its Board of Directors. Mr. Phillips is the Founder of Visible Men and the Co-Founder and CEO of Visible Men Academy. He has over 30 years of experience as an educator, entrepreneur, and youth advocate. Neil is regarded as a national thought leader and renowned speaker on black male achievement, race in America, and youth empowerment. "We are excited to welcome Neil as an independent board member," said Mike Damaso, Partner at CBAM. "His exceptional experience as a leader, educator, and mentor will prove invaluable in ensuring our firm has true diversity of thought and perspective at all levels as we look to make a positive impact for our clients, employees and all other stakeholders." "Having known Neil for many years now, I am proud to welcome him to the CBAM team. Neil's experience and accomplishments reflect a life-long dedication to building a society of diversity and inclusion, values that are at the core of our firm here at CBAM." Said Don Young, Partner at CBAM. "I look forward to joining CBAM's board to help grow and position the organization for long-term success," Phillips said. "CBAM's inclusive and collaborative culture and emphasis on personal and professional growth align with my values and background. I am excited about the opportunities the firm has ahead of it across its operations and activities and look forward to providing my guidance to its leadership as they seize those opportunities." In addition to his role as the Founder of Visible Men and the Co-Founder and CEO of Visible Men Academy Mr. Phillips serves on the Board of Directors for the Nantucket Project and served on the Board of Directors for Washington Jesuit Academy in Northeast Washington D.C. and the United Way of Manatee County, Florida. Prior to founding Visible Men, he served as the Assistant Headmaster at the Landon School in Bethesda, MD and as Interim Head of Upper School at the Out-of-Door Academy in Sarasota, Florida. Mr. Phillips is an Aspen Institute Pahara Fellow. He is a member of the inaugural Echoing Green/Open Society Foundations Black Male Achievement Fellowship. Neil was awarded for his talk, "Race to Truth" and his onstage conversations with Norman Lear (2016) and former President, George W. Bush (2018). He earned his B.A. in English and American Literature from Harvard University. About CBAM CBAM Partners, LLC an Eldridge business, is an investment management firm and SEC-registered investment adviser founded in 2016 by Don Young, Mike Damaso, and Jay Garrett, headquartered in New York. With $12.1 billion of AUM, CBAM specializes in opportunities across the credit spectrum for institutional clients through separately managed accounts, CLOs, and private funds. To learn more about CBAM please visit www.cbam.com Media Contact Prosek PartnersJosh Clarkson / Geoffrey Bayers [emailprotected]/ [emailprotected] Investor Contact CBAM John Bedford 212-603-3106 [emailprotected] SOURCE CBAM

Neil Phillips Appointed to the CBAM Board of Directors

ALISO VIEJO, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd. (ASX: BRN), a leading provider of ultra-low power high performance AI technology, today announced that Chief Development Officer Anil Mankar will present A Neuromorphic Processor for Power Efficient Edge AI Applications at the Linley Fall Processor Conference 2020 October 20 at 9:30 a.m. PDT. BrainChips presentation is part of the conferences first-day session AI in Edge Devices. As part of the presentation, Mankar will provide an update on the AKD1000, BrainChips first Neural network SoC (NSoC), and describe the advantages of processing information in the event-domain. A 10-minute Q&A session will immediately follow the conclusion of his speech. Many edge-AI processors take advantage of the spatial sparsity in neural network models to eliminate unnecessary computations and save power, said Mankar. But neuromorphic processors achieve further savings by performing event-based computation, which exploits the temporal sparsity inherent in data generated by audio, vision, olfactory, lidar, and other edge sensors. I look forward to sharing with attendees of the Linley Conference how this unique approach is revolutionizing artificial intelligence at the edge. The companys Akida Neural Processor technology, which is implemented in the Neuromorphic System-on-Chip (NSoC), is a revolutionary advanced neural networking processor that brings artificial intelligence to the edge in a way that existing technologies are not capable. The solution is high-performance, small, ultra-low power and enables a wide array of edge capabilities. The Akida NSoC represents a revolutionary new breed of Neural Processing computing devices for Edge AI devices and systems. Comparisons to leading DNN accelerator devices show significantly better images/second/watt running industry standard benchmarks with MobileNet, MobileNet-SSD and Key Word Spotting, while maintaining excellent accuracy. "Industry demand for AI performance has skyrocketed over the last few years, driven by rapid adoption from the data center to the edge, said Linley Gwennap, principal analyst at the Linley Group and Linley Fall Processor Conference chairperson. This year's Linley Fall Processor Conference will feature our biggest program yet and will introduce a host of new technology disclosures and product announcements of innovative processor architectures and IP technologies. In spite of the challenges posed by the pandemic, development of these technologies continues to accelerate and we're excited to be sharing these presentations with a global audience via our live-streamed format." For more than a decade, The Linley Group has delivered the industrys premier processor conference. This year, the Linley Fall Processor Conference will feature virtual presentations that run half days on October 20-22 and 27-29, 2020. Presentations will address processors and IP cores for AI applications, embedded, data center, automotive, and communications. Attendees will be able to view live-streamed presentations and interact with the speakers during Q&A, breakout sessions, or scheduled one-on-one meetings. Additional information about the event is available at https://www.linleygroup.com/events/event.php?num=49 About Brainchip Holdings Ltd (ASX: BRN) BrainChip is a global technology company that is producing a groundbreaking neuromorphic processor that brings artificial intelligence to the edge in a way that is beyond the capabilities of other products. The chip is high performance, small, ultra-low power and enables a wide array of edge capabilities that include on-chip training, learning and inference. The event-based neural network processor is inspired by the spiking nature of the human brain and is implemented in an industry standard digital process. By mimicking brain processing BrainChip has pioneered a processing architecture, called Akida, which is both scalable and flexible to address the requirements in edge devices. At the edge, sensor inputs are analyzed at the point of acquisition rather than through transmission via the cloud to a data center. Akida is designed to provide a complete ultra-low power and fast AI Edge Network for vision, audio, olfactory and smart transducer applications. The reduction in system latency provides faster response and a more power efficient system that can reduce the large carbon footprint of data centers. Additional information is available at https://www.brainchipinc.com Follow BrainChip on Twitter: https://www.twitter.com/BrainChip_inc Follow BrainChip on LinkedIn: https://www.linkedin.com/company/7792006

BrainChip Presents on AI in Edge Devices at Linley Fall Processor Conference 2020

COPENHAGEN,Denmark, April 28,2021 /PRNewswire/ --Astralis(ASTRLS),basedin Copenhagen focusedonesports and media rights,todayannouncedthatNicolai Nyholm, Founder and Chairman,willpresent liveatVirtualInvestorConferences.comonApril29th. DATE: Thursday, April 29thTIME: 11:30 AM ETLINK: https://bit.ly/2QfbeEE Thiswillbealive,interactiveonlineeventwhereinvestorsareinvitedtoaskthecompany questionsinrealtime.Ifattendeesarenotabletojointheeventliveonthedayofthe conference,anarchivedwebcastwillalsobemadeavailableaftertheevent. Itisrecommendedthatinvestorspreregisterandruntheonlinesystemchecktoexpedite participationandreceiveeventupdates. Learn more about the event at www.virtualinvestorconferences.com. About Astralis Astralis is one of the most recognized brands and afrontrunnerin the global esports industry with winning teams in League of Legends, Counter-Strike and FIFA. Astralisholdspermanent participation rights in the premium,international leagues for League of Legends (LEC) and Counter-Strike (ESL Pro League and BLASTPremier). In 2019 Astralis was listed and is traded on Nasdaq Copenhagen. About Virtual Investor ConferencesVirtualInvestorConferences(VIC)istheleadingproprietaryinvestorconferenceseriesthat providesaninteractiveforumforpubliclytradedcompaniestomeetandpresentdirectlywith investors. Arealtimesolutionforinvestorengagement,VirtualInvestorConferencesispartofOTC MarketGroup'ssuiteofinvestorrelationsservicesspecificallydesignedformoreefficient InvestorAccess.Replicatingthelookandfeelofonsiteinvestorconferences,VirtualInvestor Conferences combine leadingedge conferencing and investor communications capabilities with acomprehensiveglobalinvestoraudiencenetwork. SOURCE VirtualInvestorConferences.com Related Links http://www.virtualinvestorconferences.com

Astralis to Webcast Live at VirtualInvestorConferences.com April 29th Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

NEW YORK, Oct. 7, 2020 /PRNewswire/ -- SiriusXM'sThe Beatles Channelis honoringJohn Lennon's 80th birthday on October 9 with exclusive programming featuring special guestsPaul McCartney,Alec Baldwin,Sean Ono Lennon, and more.Listeners will hear celebrities pay tribute to Lennon, as well as exclusive specials about his music and legacy on The Beatles Channel. (PRNewsfoto/Sirius XM Holdings Inc.) The weekend-long programming will include a new show, featuring Paul McCartney in conversation with Alec Baldwin. The exclusive show will feature McCartney reflecting on his songwriting partner, bandmate, and friend John Lennon. The special will air on Friday, October 9 at 11:00 am ET, 4:00 pm ET and 9:00 pm ET on SiriusXM radios (channel 18) and on the SiriusXM app. The special will also air multiple times on The Beatles Channel throughout the weekend and will be available On Demand via the SiriusXM app after its debut. Select audio clips below from Paul McCartney and Alec Baldwin's conversation:Paul McCartney And Alec Baldwin on John Lennon, The Leaderhttps://www.youtube.com/watch?v=TS3UXNay_ZY"The three others of us in the group were massive fans of John because he was that kind of guy. He was, I mean, we always used to get asked, 'who's the leader of the group' and I'd go, 'me' and John wouldgo, 'no me.'" "I have to admit, we really, that it was sort of John, just his personality was a leader's personality. Luckily it didn't matter. We were, we all had an equal vote and so it always worked out without worrying about that."Paul McCartney And Alec Baldwin On John Lennon At 80https://www.youtube.com/watch?v=rsZrgwHWRV4"It's lovely to think he would have been 80. And, you know, that's, that's, it's nice to imagine him at 80.""I think he would, I think he would be, very literate. I think he would be writing, uh, not necessarily just music cause he was starting to get into, uh, he did, he did a couple of little books. Um, and I think, I think he would have matured nicely."Paul McCartney And Alec Baldwin On The Women In John Lennon's Lifehttps://www.youtube.com/watch?v=Vck0eYkfisw"When he met Yoko, she was so different. And the two of them were such a sort of tight little unit that they, she was showing him new things in life and a new kind of life. And John had always had strong women in his life." "When Yoko came along, uh, she was very influential and he was very happy to be influenced. It caused a bit of problems with us till we sort of realized that he had every right to do what he was doing, because he was in love. And you don't just do what everyone expects if you're in love. And he was a, he was really sort of mad, keen on her."Paul McCartney And Alec Baldwin On "Kansas City"https://www.youtube.com/watch?v=rNSHNGwyTDI"I remember, uh, Kansas City, the, the Richard, Little Richard song. And I'd been talking to John weeks before and he said, 'how'd you do that voice? You know, that, that Little Richard voice.' I said, 'I don't know.' I said, 'he's somebody just comes out at the top of my head.' And he said, 'Oh, Hmm.' So here's me. I've, I've, it's not working. And I'm trying to do Kansas City and I'm struggling. I'm at the mic. I can't get, I can't get in the pocket. You know? So when he comes down from the control room, we've been listening, he said, he goes with me, he goes, 'remember, comes out the top of your head.' I go, 'yeah.' And then I do the take that, you know, as The Beatles take. So, you know, we, we, we, we admired each other."Full schedule below of specialty programming airing to celebrate John Lennon on SiriusXM's The Beatles Channel.*Broadcast Schedule (all times ET)*Sean Ono Lennon Guest DJMusician, songwriter, producer, and the only child of John Lennon and Yoko Ono, Sean Ono Lennon joins host David Fricke in a two-part series, sharing memories of his dad along with his favorite John Lennon songs, both with and without The Beatles.Part 1 Saturday, October 10 at 1pmPart 2 Sunday, October 11 at midnightThe Ballad Of John And Yoko: 1969It's hard toimaginethe life of John and Yoko in 1969 The Beatles, Plastic Ono Band, The Bed-Ins for Peace, War Is Over it's a story only they can tell. Listen to John and Yoko talk about their lives and thoughts on many topics in their own words from 1969.Friday, October 9 at 11pmSunday, October 11 at 10amEight Songs A Week Times TwoBeatles fans are giving John Lennon a special birthday playlist composed of their 16 favorite songs with John on lead vocals. It'sEight Songs A WeekTimes Two!Friday, October 9 at 1pmSaturday, October 10 at 10amSunday, October 11 at 1pmMonday, October 12 at 12pmImagine SpecialBill Flanagan explores John Lennon'sImagine: "The Ultimate Collection"in a two-part series. Hear the original masters, alternate versions, and interviews with those who were part of the creation of the landmark album.Imagine New York Special Saturday, October 10 at 6pmImagine UK SpecialSunday, October 11 at 3pmMagical Lennon Maxi ConcertIn honor of John's birthday, The Beatles Channel has imagined the greatest John Lennon concert ever! Sixty minutes of Lennon, Beatles and solo hits live.Saturday, October 10 at 9pmFab FourumThe Beatles Channel's weekly liveFab Fourumtalk show, hosted by Dennis Elsas and Bill Flanagan, will be dedicated to John on his birthday and feature special guests, as well as your phone calls, plus the chance to win an Epiphone guitar and the newJOHN LENNON: GIMME SOME TRUTHdeluxe edition box set.Wednesday, October 7 at 9pmSaturday, October 10 at 7amSunday, October 11 at 6pmNorthern SongsBeatles historian and author Bill Flanagan puts together a themed playlist of hits and rarities by the Fab Four for this weekly audio adventure. This week, it's all about John Lennon's songs with The Beatles in honor of his 80th birthday.Friday, October 9 at midnightSaturday, October 10 at 7pmSunday, October 11 at 6amPeter Asher: From Me To YouMusician, host, and friend of The Beatles Peter Asher explores the connection between John Lennon and legendary author Lewis Carroll, plus anImagineset, Plastic Ono Band, and more.Thursday, October 8 at 9pmSaturday, October 10 at 5pmSunday, October 11 at 8amTuesday, October 13 at 1pmDark Horse RadioIn this weekly show dedicated to the music that George Harrison wrote, produced, sang and loved, musician and host Laura Cantrell will explore the special relationship between George and John Lennon.Thursday, October 8 at 3pmSaturday, October 10 at 11pmSunday, October 11 at 4pmTuesday, October 13 at 1amThe Beatles Channel, SiriusXM's channelcreatedin collaboration with and fully authorized by The Beatles' Apple Corps Ltd., celebrates popular music's most legendary and influential band, showcasing all-things-Beatles with regular and special programming spanning the history-making careers of the band and its members:John Lennon,Paul McCartney,George HarrisonandRingo Starr. The channel explores The Beatles' entire career including their hits and deeper tracks, live recordings, rarities, and solo albums, while also spotlighting musicians who have inspired, and have drawn inspiration from, The Beatles. The Beatles Channel presents a curated mix of music tailored to a wide range of Beatles fans, along with a variety of regular shows and specials.Paul McCartney and Alec Baldwin photo click here. About SiriusXMSirius XM Holdings Inc. (NASDAQ: SIRI) is the leading audio entertainment company in the U.S., and the premier programmer and platform for subscription and digital advertising-supported audio products. Pandora, a subsidiary of SiriusXM, is the largest ad-supported audio entertainment streaming service in the U.S. SiriusXM and Pandora together reach more than 100 million people each month with their audio products. SiriusXM, through Sirius XM Canada Holdings, Inc., also offers satellite radio and audio entertainment in Canada. In addition to its audio entertainment businesses, SiriusXM offers connected vehicle services to automakers. For more about SiriusXM, please go to: www.siriusxm.com.This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "believe," "intend," "plan," "projection," "outlook" or words of similar meaning. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements.The following factors, among others, could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements: the current coronavirus (COVID-19) pandemic is adversely impacting our business;our substantial competition that is likely to increase over time; our efforts to attract and retain subscribers and listeners, or convert listeners into subscribers, which may not be successful, and may adversely affect our business; our Pandora ad-supported business has suffered a loss of monthly active users, which may adversely affect our Pandora business; privacy and data security laws and regulations may hinder our ability to market our services, sell advertising and impose legal liabilities; we engage in extensive marketing efforts and the continued effectiveness of those efforts are an important part of our business; consumer protection laws and our failure to comply with them could damage our business; a substantial number of our Sirius XM subscribers periodically cancel their subscriptions and we cannot predict how successful we will be at retaining customers; our ability to profitably attract and retain subscribers to our Sirius XM service as our marketing efforts reach more price-sensitive consumers is uncertain; our failure to convince advertisers of the benefits of our Pandora ad-supported service could harm our business; if we are unable to maintain revenue growth from our advertising products, particularly in mobile advertising, our results of operations will be adversely affected; if we fail to accurately predict and play music, comedy or other content that our Pandora listeners enjoy, we may fail to retain existing and attract new listeners; if we fail to protect the security of personal information about our customers, we could be subject to costly government enforcement actions and private litigation and our reputation could suffer; interruption or failure of our information technology and communications systems could impair the delivery of our service and harm our business; we rely on third parties for the operation of our business, and the failure of third parties to perform could adversely affect our business; our business depends in part upon the auto industry; our Pandora business depends in part upon consumer electronics manufacturers; the market for music rights is changing and is subject to significant uncertainties; our ability to offer interactive features in our Pandora services depends upon maintaining licenses with copyright owners; the rates we must pay for "mechanical rights" to use musical works on our Pandora service have increased substantially and these new rates may adversely affect our business; failure of our satellites would significantly damage our business; our Sirius XM service may experience harmful interference from wireless operations; failure to comply with FCC requirements could damage our business; economic conditions, including advertising budgets and discretionary spending, may adversely affect our business and operating results; if we are unable to attract and retain qualified personnel, our business could be harmed; we may not realize the benefits of acquisitions or other strategic investments and initiatives, including the acquisition of Pandora; our use of pre-1972 sound recordings on our Pandora service could result in additional costs; we may from time to time modify our business plan, and these changes could adversely affect us and our financial condition; we have a significant amount of indebtedness, and our debt contains certain covenants that restrict our operations; our facilities could be damaged by natural catastrophes or terrorist activities; the unfavorable outcome of pending or future litigation could have an adverse impact on our operations and financial condition; failure to protect our intellectual property or actions by third parties to enforce their intellectual property rights could substantially harm our business and operating results; some of our services and technologies may use "open source" software, which may restrict how we use or distribute our services or require that we release the source code subject to those licenses; rapid technological and industry changes and new entrants could adversely impact our services; existing or future laws and regulations could harm our business; we may be exposed to liabilities that other entertainment service providers would not customarily be subject to; our business and prospects depend on the strength of our brands; we are a "controlled company" within the meaning of the NASDAQ listing rules and, as a result, qualify for, and rely on, exemptions from certain corporate governance requirements; while we currently pay a quarterly cash dividend to holders of our common stock, we may change our dividend policy at any time; and our principal stockholder has significant influence, including over actions requiring stockholder approval, and its interests may differ from the interests of other holders of our common stock. Additional factors that could cause our results to differ materially from those described in the forward-looking statements can be found in our Annual Report on Form 10-K for the year ended December 31, 2019 and Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, which are filed with the Securities and Exchange Commission (the "SEC") and available at the SEC's Internet site (http://www.sec.gov). The information set forth herein speaks only as of the date hereof, and we disclaim any intention or obligation to update any forward looking statements as a result of developments occurring after the date of this communication.Source: SiriusXMMedia contact:Angela Burke [emailprotected]Carolina Dubon[emailprotected]SOURCE Sirius XM Holdings Inc. Related Links http://www.siriusxm.com

Paul McCartney and Alec Baldwin to Honor John Lennon's 80th Birthday on SiriusXM's The Beatles Channel

ROCKVILLE, Md., March 13, 2020 /PRNewswire/ -- Dr. Joe Kravitz of Kravitz Dentistry warns that toothbrushes may spread diseases such a periodontal disease, cavities, the flu and viruses. Many family members store their toothbrushes together in the bathroom, which can be dangerous.Dr. Joseph Kravitz, award-winning dental implants dentist located in Rockville, Maryland, is focused on the prevention of oral and systemic diseases, including COVID-19 / Coronavirus. Continue Reading Dr. Joe Kravitz, Rockville, MD "Purchase new toothbrushes and boil them between brushings to prevent the spread of diseases such the flu and other viruses to you, your family, classmates and coworkers," states Dr. Kravitz. "The Centers for Disease Control and the World Health Organization have shown that high temperatures kill viruses, bacteria and fungi. Therefore, boiling your toothbrushes reduces the chance of reinfection and spread of the germs to other family members, coworkers, classmates and the community." As shown in his book, Dirty Mouth, germs may grow in your mouth at the rate of 20 billion per hour between brushings. After brushing, the tooth brush is wet, allowing for germs like a virus to continue to live. Boiling your toothbrush can kill the virus allowing for future brushing to be free of harmful germs.Dr. Kravitz has pioneered many minimally invasive surgical techniques, smile innovations, and improvements to the delivery of dental health care. Other dentists seek out instruction and mentorship from Dr. Kravitz, based on his extensive professional history of credentials including a Doctorate of Dental Surgery and a Specialty Certificate in Prosthodontics from the University of Maryland Dental School, a Master of Science in Oral Biology from the University of Maryland Graduate School, and a Fellowship in Implant Dentistry from NYU College of Dentistry. It's important to visit your dentist to reduce the presence of periodontal disease, cavities, infections and cracked teeth for they all can weaken your immune system. People with a weakened immune system are most susceptible diseases such as the flu and viruses.About Kravitz DentistryKravitz Dentistry, PC is a specialty dental practice utilizing a simple, beautiful and pain-free approach to treating the smile, located in Rockville, Maryland. Using state-of-the-art techniques and diagnostic tools, Kravitz Dentistry offers kind, friendly, non-judgmental evaluation, beautiful and pain-free treatment and follow-up care for a variety of dental conditions, from broken teeth, missing teeth, crooked teeth, loose teeth, infected gums, infected bones, and mouth pain. For more information or to make an appointment, please visit www.KravitzDentistry.comor www.DentalImplants.usor Call 1-877-9-Kravitz or 301-761-4840.Media Contact:Dr. Joe KravitzDDS, MS301-761-4840https://drjosephkravitz.com/ SOURCE Kravitz Dentistry Related Links http://www.kravitzdentistry.com

Maryland Dentist Recommends Boiling Toothbrushes; Stop the Spread of Disease in 2020 and Beyond

BOSTON--(BUSINESS WIRE)--Heres a guide to the best early Powerbeats Pro totally wireless earphones deals for Black Friday 2020, featuring offers on more Powerbeats true wireless headphones by Beats by Dr Dre. Browse the latest deals by clicking the links listed below. Best Powerbeats Deals: Best Beats by Dre Deals: Want some more deals? Check out Walmarts Black Friday Deals for Days sale and Amazons latest holiday season deals to compare hundreds more active discounts right now. Retail Fuse earns commissions from purchases made using the links provided. The Powerbeats Pro can deliver up to 9 hours of listening time with a rich, clear sound field that has as much power as it does the definition. Its sweat & water-resistant, with adjustable, secure-fit ear hooks (with multiple ear tip options) that stay in place and move seamlessly with the user. The Powerbeats Pro also has a 5-minute Fast Fuel charging, which delivers up to 1.5 hours of playback when the battery is low. Aside from this, it features volume & track controls on each earbud, powered by Class 1 Bluetooth via Apple H1 chip, which allows for improved connection speed with extended range and fewer dropouts. About Retail Fuse: Retail Fuse reports the latest retail news. As an Amazon Associate and affiliate Retail Fuse earns from qualifying purchases.

The Best Black Friday Powerbeats Pro Deals 2020: Early Wireless Earphones Savings Tracked by Retail Fuse Check out our summary of the top early Powerbeats Pro totally wireless earphones deals for Black Friday, including sales on Beats by Dr Dre wireless headphones

FOOTHILL RANCH, Calif., Feb. 18, 2021 /PRNewswire/ --loanDepot, Inc. and its subsidiaries (NYSE: LDI) (collectively, "loanDepot" or the "Company"), the innovative consumer lending and real estate services provider that is using its proprietary mello technology to deliver best-in-class experiences to its customers, today announced results for the fourth quarter and year ended December 31, 2020. loanDepot's assets are unlike any other lender in the marketplace today: Diversified strategy: Integrated at-scale refinance and purchase business ensures that loanDepot thrives in any mortgage market. The Retail strategy has 2,300+ employee loan officers serving customers online and in local markets nationwide. The Partner strategy has significant relationships with some of the largest home builders, financial institutions, real estate and mortgage brokers across the nation. Data and Analytics: loanDepot has harnessed the power of its data science and proprietary AI and machine learning models, dramatically widening the Company's top-of-funnel marketing reach, gaining market share, significantly driving down customer acquisition cost and increasing sales productivity. Brand: loanDepot has the second-most recognized brand in the industry today and has continued to invest in its brand strength through the "Home Means Everything" national ad campaign and partnership with Major League Baseball as its exclusive mortgage partner. Technology: loanDepot's proprietary technology platform, mello, is core to all operations, which maximizes loan officer closings, reduces cycle times and improves customer satisfaction. mello also allows the Company to easily add new products and services, whether organic or acquired. "I'm incredibly proud of and humbled by our record-breaking 2020 performance and thank our team members for their passionate commitment to our customers during an unprecedented year," said Founder and CEO Anthony Hsieh. "Customers gravitate to the loanDepot brand because we think and do differently. We are able to efficiently and effectively serve homeowners and future homeowners through our Retail and Partner channels, with the best proprietary data science, AI, machine learning and technology available, which ensures we are serving customers the way they wish to be served through the most important financial transaction of their lives. As we continue our growth trajectory and expand our product and service offerings, we will do so in a way that delivers satisfaction and value for our customers, partners, team members and shareholders for decades to come." Fourth Quarter Earnings CallManagement will host a conference call and live webcast today at 11:00 a.m. ET on loanDepot's Investor Relations website, investors.loandepot.com, following the release of its earnings results. Financial Summary Three Months Ended Year Ended ($ in thousands) (Unaudited) December 31,2020 September 30,2020 December 31,2019 December 31,2020 December 31,2019 Rate lock volume $ 49,711,270 $ 49,280,386 $ 20,347,563 $ 160,984,531 $ 75,262,459 Loan origination volume 37,395,352 27,157,669 16,055,972 100,760,151 45,324,026 Gain on sale margin 3.38 % 4.98 % 2.36 % 4.27 % 2.81 % Financial Results Total revenue $ 1,298,394 $ 1,368,930 $ 415,292 $ 4,312,174 $ 1,337,131 Total expense 750,433 640,014 401,116 2,296,816 1,304,460 Net income 547,170 728,349 16,213 2,013,110 34,420 Non-GAAP Financial Measures(1) Adjusted total revenue $ 1,252,707 $ 1,345,550 $ 407,197 $ 4,252,907 $ 1,346,178 Adjusted net income 375,711 524,819 4,675 1,461,617 31,885 Adjusted EBITDA 530,364 745,499 29,499 2,084,536 124,005 (1)We believe Adjusted Total Revenue, Adjusted EBITDA, and Adjusted Net Income provide useful information to investors regarding our results of operations because each measure assists both investors and management in analyzing and benchmarking the performance and value of our business. They facilitate company-to-company operating performance comparisons by backing out potential differences caused by variations in hedging strategies, changes in valuations, capital structures (affecting net interest expense), taxation, the age and book depreciation of facilities (affecting relative depreciation expense) and the amortization of intangibles, which may vary for different companies for reasons unrelated to operating performance, as well as certain historical cost (benefit) items which may vary for different companies for reasons unrelated to operating performance. See "Non-GAAP Financial Measures" for a discussion of how we define and calculate Adjusted Total Revenue, Adjusted EBITDA and Adjusted Net Income. Operational Results Record rate lock volume of $49.7 billion during the fourth quarter of 2020 resulted in quarterly total revenue of $1.3 billion. Fourth quarter 2020 revenue declined by $70.5 million, or 5%, from the third quarter of 2020 due to gain on sale margins returning to a more normalized level of 3.38% during the fourth quarter of 2020. For the year ended December 31, 2020, rate lock volume set a Company record at $161.0 billion resulting in total revenue of $4.3 billion from gain on sale margin of 4.27%. Loan origination volume for the fourth quarter of 2020 was also a record at $37.4 billion, an increase of $10.2 billion or 38% from the third quarter of 2020. Loan origination volume for the year ended December 31, 2020 totaled $100.8 billion, an increase of 122% from loan origination volume for the year ended December 31, 2019. Our Retail and Partner strategies delivered a record $28.3 billion of purchase loan originations during 2020, which represented an increase of 53% from the prior year, while refinance loan originations of $72.5 billion represented an increase of over 170% for the year. Net income for the fourth quarter of 2020 decreased to $547.2 million as compared to $728.3 million in the prior quarter. Adjusted net income for the fourth quarter of 2020 decreased to $375.7 million as compared to $524.8 million for the third quarter of 2020. The quarter over quarter decreases were driven by the decline in gain on sale margin and increased expenses from higher loan origination volume. For the year ended December 31, 2020, net income totaled $2.0 billion and adjusted net income totaled $1.5 billion. Total expenses for the fourth quarter 2020 increased $110.4 million, or 17% from the third quarter 2020, due to higher direct expenses on record loan originations, additional personnel and related expenses to support the growth in our business and higher marketing costs as we expanded our national brand campaign. During the fourth quarter of 2020, our team members grew by 15% to 9,892 compared to our 38% growth in loan originations, which demonstrates our ability to rapidly grow and improve efficiency. Disciplined and purposeful investments in the Company's technology enabled an 8% decline in cost per loan for the full year 2020 as compared 2019. Our data driven marketing efforts and servicing expertise resulted in a customer acquisition cost decline of 28% year over year as well. Other Highlights On February 11, 2021, the Company completed its initial public offering. Since loanDepot did not have any shares outstanding prior to this date, earnings per share information was not determinable. As of February 11, 2021, the Company had 6,068,834 of Class A shares outstanding, 179,431,851 of Class C shares outstanding and 120,642,007 of Class D shares outstanding. During the fourth quarter of 2020, the Company donated $2.0 million on behalf of our employees to support individuals and families impacted by COVID-19 as well as to support several key charitable organizations. These donations bring the total amount donated in 2020 to support pandemic-relief and philanthropic efforts to $3.0 million. In February of 2021, we entered into a multi-year partnership agreement with Major League Baseball wherein loanDepot was named "Official Mortgage Provider" of Major League Baseball. This partnership further expands our brand reach and reinforces our brand promise to millions of MLB fans nationwide. We believe our position as the second most recognized mortgage brand grew even stronger through our ongoing national television ad campaign delivering over 7 billion household impressions from May through December 2020. Our extensive data analytics also allowed us to capitalize on the 1.6 million average monthly website visits and 330 million online media exposures during the fourth quarter of 2020. Balance Sheet Highlights % Change ($ in thousands) (Unaudited) December 31,2020 September 30,2020 December 31,2019 Dec - 20vsSep - 20 Dec - 20vs.Dec - 19 Cash and cash equivalents $ 284,224 $ 637,511 $ 73,301 (55.4) % 287.7 % Loans held for sale, at fair value 6,955,424 4,888,364 3,681,840 42.3 88.9 Servicing rights, at fair value 1,127,866 780,451 447,478 44.5 152.0 Warehouse and other lines of credit 6,577,429 4,601,062 3,466,567 43.0 89.7 Total liabilities 9,236,615 7,017,792 4,576,626 31.6 101.8 Total equity 1,656,613 1,633,521 375,885 1.4 340.7 Record quarterly originations drove an increase in loans held for sale at December31, 2020, which increased by 42% from the prior quarter to $7.0 billion. The balance on our warehouse lines of credit increased by 43% during the quarter due to the increased origination activity. Total funding capacity with our lending partners increased to $8.1 billion at December31, 2020 from $5.5 billion at September 30, 2020. The increase of $2.6 billion was due to the addition of two new facilities with two and three year maturity dates as well as increases to existing facilities. Available borrowing capacity was $1.5 billion at December 31, 2020. Unrestricted cash and cash equivalents was $284.2 million at December31, 2020. The decrease in cash from September 30, 2020 was primarily due to earnings offset by tax distributions of $71.1 million as required under the Company's operating agreement and profit distributions of $453.8 million as allowed under the Company's operating agreement. The fair value of mortgage servicing rights increased by 45%, or $347.4 million during the fourth quarter to a record $1.1 billion. This increase was driven by $411.3 million of new additions, partially offset by runoff of $80.0 million. During the fourth quarter of 2020, servicing retained loan sales increased as a result of the record level of loan originations. Strategic Channel OverviewOur diverse origination strategy ensures we can serve customers in the way they want to be served, with the right mortgage professional, with the right product, at the right price, at the right time. Complementing our origination strategy is our servicing portfolio, which ensures we can serve the customer through their entire mortgage journey. Retail Channel Three Months Ended Year Ended ($ in thousands)(Unaudited) December 31,2020 September 30,2020 December 31,2019 December 31,2020 December 31,2019 Volume data: Rate locks $ 40,066,201 $ 40,903,946 $ 15,854,996 $ 132,448,124 $ 59,116,290 Loan originations 29,665,251 21,714,871 11,409,261 80,256,667 32,700,837 Gain on sale margin 3.47 % 5.07 % 2.87 % 4.41 % 3.39 % The Company employs more than 2,300 licensed mortgage loan professionals who work in our Retail Channel that reach customers through our organic marketing or their own relationships in either our proprietary call centers or local in-market branches. During the fourth quarter of 2020, our Retail Channel accounted for $29.7 billion, or 79%, of our loan originations. For the year ended December 31, 2020, our Retail Channel contributed $80.3 billion, or 80%, of loan originations. Partner Channel Three Months Ended Year Ended ($ in thousands)(Unaudited) December 31,2020 September 30,2020 December 31,2019 December 31,2020 December 31,2019 Volume data: Rate locks $ 9,645,069 $ 8,376,440 $ 4,492,567 $ 28,536,407 $ 16,146,169 Loan originations 7,730,101 5,442,799 4,646,711 20,503,484 12,623,189 Gain on sale margin 2.58 % 4.06 % 1.19 % 3.06 % 1.16 % Our Partner Channel originates loans through our network of approved mortgage brokers, as well as a series of exclusive joint ventures with some of the nation's largest homebuilders and depositories, who market our broad spectrum of products utilizing our innovate mello technology platform to efficiently underwrite, process and fund mortgage loans, while delivering an exceptional customer experience. During the fourth quarter of 2020, our Partner Channel accounted for $7.7 billion, or 21%, of our loan originations. For the year ended December 31, 2020, our Partner Channel contributed $20.5 billion, or 20%, of our loan originations. The returns were complemented by $3.7 million of income recorded from our joint ventures for the fourth quarter of 2020 and $10.4 million for the year ended December 31, 2020, reflecting the wide variety of industry partners we work with in the channel. We entered into two new joint venture relationships with home builders during the second half of 2020 and added one new joint venture relationship in the first quarter of 2021 with a federally chartered savings bank offering banking and insurance services. Servicing % Change Servicing Portfolio Data: ($ in thousands) (Unaudited) December 31, 2020 September 30, 2020 December 31, 2019 Dec - 20vsSep - 20 Dec - 20vs.Dec - 19 Total servicing portfolio (unpaid principal balance) $ 102,931,258 $ 77,171,998 $ 36,336,126 33.4 % 183.3 % Total servicing portfolio (units) 342,600 272,701 148,750 25.6 130.3 60+ days delinquent ($) $ 2,162,585 $ 2,073,862 $ 383,272 4.3 % 464.2 % 60+ days delinquent (%) 2.1 % 2.7 % 1.1 % Servicing rights, net $ 1,124,302 $ 776,993 $ 444,443 44.7 153.0 The unpaid principal balance of our servicing portfolio increased $66.6 billion, or 183%, to $102.9 billion compared to $36.3 billion as of December 31, 2019. The fourth quarter of 2020 comprised $25.8 billion, or 39% of the total $66.6 billion increase throughout the year, driven by an increase in servicing-retained loan sales. We continued to invest in growing our high quality servicing portfolio and not only increased total loan originations but also the percentage of our servicing customers who chose to refinance with us. For the fourth quarter of 2020, our organic refinance consumer direct recapture rate was 66%, highlighting the efficacy of our marketing efforts and the strength of our customer relationships. Servicing income increased $67.5 million, or 57% to $185.9 million for the year compared to $118.4 million for 2019, and increased $16.0 million, or 33% to $64.4 million for the fourth quarter of 2020 compared to $48.4 million for the third quarter of 2020. As of December 31, 2020, approximately 2.4%, or $2.4 billion, of our servicing portfolio was in active forbearance. This represents a decline from 3.4%, or $2.6 billion, at the end of the third quarter of 2020. GuidanceWe expect analyst research to be published and coverage of loanDepot, Inc. to begin in the near future and anticipate providing updated guidance on first quarter 2021 performance after those publications. Consolidated Statements of Operations ($ in thousands) Three Months Ended Year Ended December 31, 2020 September 30, 2020 December 31, 2019 2020 2019 (Unaudited) (Unaudited) REVENUES: Interest income $ 44,730 $ 31,453 $ 41,076 $ 142,879 $ 127,569 Interest expense (42,562) (29,553) (40,794) (131,443) (130,344) Net interest income 2,168 1,900 282 11,436 (2,775) Gain on origination and sale of loans, net 1,172,704 1,279,431 337,798 4,046,159 1,125,853 Origination income, net 91,253 71,740 41,651 258,807 149,500 Servicing fee income 64,375 48,406 33,396 185,895 118,418 Change in fair value of servicing rights, net (68,389) (57,603) (19,495) (284,521) (119,546) Other income 36,283 25,056 21,660 94,398 65,681 Total net revenues 1,298,394 1,368,930 415,292 4,312,174 1,337,131 EXPENSES: Personnel expense 508,638 441,818 239,308 1,531,371 765,256 Marketing and advertising expense 90,709 60,435 54,081 264,337 187,880 Direct origination expense 36,127 33,465 31,743 124,754 93,531 General and administrative expense 51,146 52,372 32,786 171,712 100,493 Occupancy expense 9,826 9,997 9,520 39,262 37,209 Depreciation and amortization 8,547 8,585 10,116 35,669 37,400 Subservicing expense 29,556 22,820 12,660 81,710 41,397 Other interest expense 15,884 10,522 10,902 48,001 41,294 Total expenses 750,433 640,014 401,116 2,296,816 1,304,460 Income before income taxes 547,961 728,916 14,176 2,015,358 32,671 Income tax expense (benefit) 791 567 (2,037) 2,248 (1,749) Net income 547,170 728,349 16,213 2,013,110 34,420 Net income attributable to noncontrolling interests 547,170 728,349 16,213 2,013,110 34,420 Net income attributable to loanDepot, Inc. $ $ $ $ $ Consolidated Balance Sheets ($ in thousands) December 31,2020 September 30,2020 December 31,2019 (Unaudited) ASSETS Cash and cash equivalents $ 284,224 $ 637,511 $ 73,301 Restricted cash 204,465 70,387 44,195 Accounts receivable, net 138,122 118,400 121,046 Loans held for sale, at fair value 6,955,424 4,888,364 3,681,840 Derivative assets, at fair value 647,939 722,149 131,228 Servicing rights, at fair value 1,127,866 780,451 447,478 Property and equipment, net 85,002 76,250 80,897 Operating lease right-of-use asset 66,433 56,449 61,693 Prepaid expenses and other assets 77,241 57,610 52,653 Loans eligible for repurchase 1,246,158 1,184,015 197,812 Investments in joint ventures 17,528 16,773 17,030 Goodwill and other intangible assets, net 42,826 42,954 43,338 Total assets $ 10,893,228 $ 8,651,313 $ 4,952,511 LIABILITIES AND EQUITY LIABILITIES Warehouse and other lines of credit $ 6,577,429 $ 4,601,062 $ 3,466,567 Accounts payable and accrued expenses 442,928 375,957 196,102 Derivative liabilities, at fair value 168,169 59,432 9,977 Liability for loans eligible for repurchase 1,246,158 1,184,015 197,812 Operating lease liability 86,023 72,590 80,257 Financing lease obligations 3,442 18,258 33,816 Debt obligations, net 712,466 706,478 592,095 Total liabilities 9,236,615 7,017,792 4,576,626 EQUITY Noncontrolling interest 1,656,613 1,633,521 375,885 Total liabilities and equity $ 10,893,228 $ 8,651,313 $ 4,952,511 Loan Origination and Sales Data ($ in thousands)(Unaudited) Three Months Ended Year Ended December 31,2020 September 30,2020 December 31,2019 December 31,2020 December 31,2019 Loan origination volume by type: Conventional conforming $ 31,389,431 $ 22,034,957 $ 11,005,102 $ 79,960,680 $ 29,535,192 FHA/VA/USDA 5,013,338 4,532,290 3,934,082 17,584,601 11,599,805 Jumbo 591,739 209,167 784,008 1,821,700 3,154,982 Other 400,844 381,255 332,780 1,393,170 1,034,047 Total $ 37,395,352 $ 27,157,669 $ 16,055,972 $ 100,760,151 $ 45,324,026 Loan origination volume by channel: Retail $ 29,665,251 $ 21,714,870 $ 11,409,261 $ 80,256,666 $ 32,700,837 Partnership 7,730,101 5,442,799 4,646,711 20,503,485 12,623,189 Total $ 37,395,352 $ 27,157,669 $ 16,055,972 $ 100,760,151 $ 45,324,026 Loan origination volume by purpose: Purchase $ 9,813,921 $ 8,546,295 $ 5,298,068 $ 28,301,076 $ 18,513,555 Refinance 27,581,431 18,611,374 10,757,904 72,459,075 26,810,471 Total $ 37,395,352 $ 27,157,669 $ 16,055,972 $ 100,760,151 $ 45,324,026 Loans sold: Servicing retained $ 33,989,511 $ 24,402,497 $ 7,967,753 $ 87,186,118 $ 20,360,739 Servicing released 1,394,979 1,195,252 7,382,863 10,353,541 23,134,883 Total $ 35,384,490 $ 25,597,749 $ 15,350,616 $ 97,539,659 $ 43,495,622 Loan origination margins: Gain on sale margin 3.38 % 4.98 % 2.36 % 4.27 % 2.81 % Fourth Quarter Earnings CallManagement will host a conference call and live webcast today at 11:00 a.m. ET on loanDepot's Investor Relations website, investors.loandepot.com, following the release of its earnings results. The conference call can also be accessed by dialing 833-312-1365 (domestic) or 236-712-2485 (international) using pin number 3784967. Please call five minutes in advance to ensure that you are connected prior to the call. A replay of the webcast and transcript will also be made available on the Investor Relations website following the conclusion of the event. For more information about loanDepot, please visit the company's Investor Relations website: investors.loandepot.com. Non-GAAP Financial MeasuresTo provide investors with information in addition to our results as determined by GAAP, we disclose Adjusted Total Revenue, Adjusted EBITDA, and Adjusted Net Income as non-GAAP measures. We believe Adjusted Total Revenue, Adjusted EBITDA, and Adjusted Net Income provide useful information to investors regarding our results of operations because each measure assists both investors and management in analyzing and benchmarking the performance and value of our business. They facilitate company-to-company operating performance comparisons by backing out potential differences caused by variations in hedging strategies, changes in valuations, capital structures (affecting net interest expense), taxation, the age and book depreciation of facilities (affecting relative depreciation expense) and the amortization of intangibles, which may vary for different companies for reasons unrelated to operating performance, as well as certain historical cost (benefit) items which may vary for different companies for reasons unrelated to operating performance. These measures are not financial measures calculated in accordance with GAAP and should not be considered as a substitute for revenue, net income, or any other operating performance measure calculated in accordance with GAAP, and may not be comparable to a similarly titled measure reported by other companies. We define "Adjusted Total Revenue" as total revenues, net of the change in fair value of mortgage servicing rights ("MSRs") and the related hedging gains and losses. We define "Adjusted EBITDA" as earnings before interest expense and amortization of debt issuance costs on non-funding debt, income taxes, depreciation and amortization, change in fair value of MSRs, net of the related hedging gains and losses, change in fair value of contingent consideration, stock compensation expense and management fees, and IPO related expense. We define "Adjusted Net Income" as tax-effected earnings before stock compensation expense and management fees, IPO expense, and the change in fair value of MSRs, net of the related hedging gains and losses, and the tax effects of those adjustments. Adjustments for income taxes are made to reflect LD Holdings historical results of operations on the basis that it was taxed as a corporation under the Internal Revenue Code, and therefore subject to U.S. federal, state and local income taxes. We exclude from each of these non-GAAP measures the change in fair value of MSRs and related hedging gains and losses as this represents a non-cash non-realized adjustment to our total revenues, reflecting changes in assumptions including discount rates and prepayment speed assumptions, mostly due to changes in market interest rates, which is not indicative of our performance or results of operations. We also exclude stock compensation expense, which is a non-cash expense, management fees and IPO expenses as management does not consider these costs to be indicative of our performance or results of operations. Adjusted EBITDA includes interest expense on funding facilities, which are recorded as a component of "net interest income (expense)", as these expenses are a direct operating expense driven by loan origination volume. By contrast, interest and amortization expense on non-funding debt is a function of our capital structure and is therefore excluded from Adjusted EBITDA. Adjusted Total Revenue, Adjusted EBITDA, and Adjusted Net Income have limitations as analytical tools, and you should not consider them in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are: they do not reflect every cash expenditure, future requirements for capital expenditures or contractual commitments; Adjusted EBITDA does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt; although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced or require improvements in the future, and Adjusted Total Revenue, Adjusted Net Income, and Adjusted EBITDA do not reflect any cash requirement for such replacements or improvements; and they are not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows. Because of these limitations, Adjusted Total Revenue, Adjusted EBITDA, and Adjusted Net Income are not intended as alternatives to total revenue, net income (loss), or net income attributable to the Company or as an indicator of our operating performance and should not be considered as measures of discretionary cash available to us to invest in the growth of our business or as measures of cash that will be available to us to meet our obligations. We compensate for these limitations by using Adjusted Revenue, Adjusted Net Income, and Adjusted EBITDA along with other comparative tools, together with U.S. GAAP measurements, to assist in the evaluation of operating performance. See below for a reconciliation of these non-GAAP measures to their most comparable U.S. GAAP measures. Reconciliation of Total Revenue to Adjusted Total Revenue ($ in thousands) (Unaudited) Three Months Ended Year Ended December 31, December 31,2020 September 30,2020 December 31,2019 2020 2019 Total net revenue $ 1,298,394 $ 1,368,930 $ 415,292 $ 4,312,174 $ 1,337,131 Change in fair value of servicing rights(1) (16,355) 2,930 (13,678) 95,395 51,639 Net losses (gains) from derivatives hedging servicing rights 4,525 1,981 2,383 (14,490) (20,974) Realized and unrealized (gains) losses from derivative assets and liabilities(2) (33,857) (28,291) 3,200 (140,172) (21,618) Change in fair value of servicing rights net of hedging gains and losses(3) (45,687) (23,380) (8,095) (59,267) 9,047 Adjusted total revenue $ 1,252,707 $ 1,345,550 $ 407,197 $ 4,252,907 $ 1,346,178 (1) Included in change in fair value of servicing rights, net in the Company's consolidated statements of operations. (2) Included in gain on origination and sale of loans, net in the Company's consolidated statements of operations, as shown below: ($ in thousands) (Unaudited) Three Months Ended Year Ended December 31, December 31,2020 September 30,2020 December 31,2019 2020 2019 Unrealized (losses) gains from derivative assets and liabilities $ (198,710) $ 201,003 $ (37,622) $ 320,756 $ 85,679 Less: Unrealized (losses) gains from derivative assets and liabilitiesIRLC and LHFS (209,767) 195,383 (28,830) 288,325 95,578 Unrealized gains (losses) from derivative assets and liabilitiesservicing rights 11,057 5,620 (8,792) 32,431 (9,899) Realized (losses) gains from derivative assets and liabilities (78,226) (162,191) 20,720 (450,254) (128,634) Less: Realized (losses) gains from derivative assets and liabilitiesIRLC and LHFS (101,027) (184,862) 15,128 (557,995) (160,151) Realized gains (losses) from derivative assets andliabilitiesservicing rights 22,801 22,671 5,592 107,741 31,517 Realized and unrealized gains (losses) from derivative assets and liabilities - servicing rights $ 33,857 $ 28,291 $ (3,200) $ 140,172 $ 21,618 (3) Represents the change in the fair value of servicing rights attributable to changes in assumptions, net of hedging gains and losses. Reconciliation of Net Income to Adjusted Net Income ($ in thousands) (Unaudited) Three Months Ended Year Ended December 31, December 31,2020 September 30,2020 December 31,2019 2020 2019 Net income $ 547,170 $ 728,349 $ 16,213 $ 2,013,110 $ 34,420 Income tax expense (benefit) 791 567 (2,037) 2,248 (1,749) Income before taxes 547,961 728,916 14,176 2,015,358 32,671 Adjustments to income taxes(1) 141,040 187,616 3,649 518,733 8,410 Tax-effected net income 406,921 541,300 10,527 1,496,625 24,261 Change in fair value of servicing rights, net of hedging gains and losses(2) (45,687) (23,380) (8,095) (59,267) 9,047 Stock compensation expense and management fees 1,099 1,186 215 9,565 1,219 IPO expenses 2,560 2,560 Tax effect of adjustments(3) 10,818 5,713 2,028 12,134 (2,642) Adjusted net income $ 375,711 $ 524,819 $ 4,675 $ 1,461,617 $ 31,885 (1) loanDepot, Inc. is subject to federal, state and local income taxes. Adjustments to income tax (benefit) reflect the effective income tax rates below: Three Months Ended Year Ended December 31, December 31,2020 September 30,2020 December 31,2019 2020 2019 Statutory U.S. federal income tax rate 21.00 % 21.00 % 21.00 % 21.00 % 21.00 % State and local income taxes (net of federal benefit) 4.74 % 4.74 % 4.74 % 4.74 % 4.74 % Effective income tax rate 25.74 % 25.74 % 25.74 % 25.74 % 25.74 % (2)Amounts represent the change in the fair value of servicing rights attributable to changes in assumptions, net of hedging gains and losses. (3) Amounts represent the income tax effect of (a) change in fair value of servicing rights, net of hedging gains and losses, (b) stock compensation expense and management fees, and (c) IPO expense at the aforementioned effective income tax rates. Reconciliation of Net Income to Adjusted EBITDA ($ in thousands) (Unaudited) Three Months Ended Year Ended December 31, December 31,2020 September 30,2020 December 31,2019 2020 2019 Net income $ 547,170 $ 728,349 $ 16,213 $ 2,013,110 $ 34,420 Interest expense - non-funding debt (1) 15,884 10,522 10,902 48,001 41,294 Income tax expense (benefit) 791 567 (2,037) 2,248 (1,749) Depreciation and amortization 8,547 8,585 10,116 35,669 37,400 Change in fair value of servicing rights, net of hedging gains and losses(2) (45,687) (23,380) (8,095) (59,267) 9,047 Change in fair value - contingent consideration 19,670 2,185 32,650 2,374 Stock compensation expense and management fees 1,099 1,186 215 9,565 1,219 IPO expense 2,560 2,560 Adjusted EBITDA $ 530,364 $ 745,499 $ 29,499 $ 2,084,536 $ 124,005 (1) Represents other interest expense, which includes amortization of debt issuance costs, in the Company's consolidated statement of operations. (2) Represents the change in the fair value of servicing rights attributable to changes in assumptions, net of hedging gains and losses. Forward-Looking StatementsThis press release may contain "forward-looking statements," which reflect loanDepot's current views with respect to, among other things, its operations and financial performance. You can identify these statements by the use of words such as "outlook," "potential," "continue," "may," "seek," "approximately," "predict," "believe," "expect," "plan," "intend," "estimate" or "anticipate" and similar expressions or the negative versions of these words or comparable words, as well as future or conditional verbs such as "will," "should," "would" and "could." These forward-looking statements are based on current available operating, financial, economic and other information, and are not guarantees of future performance and are subject to risks, uncertainties and assumptions, including the risks in the "Risk Factors" section of loanDepot, Inc.'s Registration Statement on Form S-1, dated February 9, 2021, which are difficult to predict. Therefore, current plans, anticipated actions, financial results, as well as the anticipated development of the industry, may differ materially from what is expressed or forecasted in any forward-looking statement. loanDepot does not undertake any obligation to publicly update or revise any forward-looking statement to reflect future events or circumstances, except as required by applicable law. About loanDepotloanDepot is a contemporary financial services company dedicated to delivering a best-in-class experience to its mortgage purchase and refinance customers. Founded in 2010, loanDepot offers a diversified network of direct-to-consumer, in-market, and partner business channels, uniquely positioning it to serve a wide range of customers. Headquartered in Southern California, the Company has funded more than $300 billion since its founding and currently ranks as the second largest retail nonbank lender and one of the leading retail mortgage lenders in the United States. Committed to serving the communities in which its team members live and work, loanDepot has donated millions of dollars to support a variety of local, regional and national philanthropic efforts, most recently giving more than $2.5 million to help with COVID-related efforts for first responders, healthcare workers, individuals and families nationwide. The Company also is a founding sponsor of War Heroes on Water, which supports ongoing therapeutic healing services for combat-wounded veterans nationwide. Investor Relations Contact:Abe GutierrezVice President, Investor Relations(949) 860-8215[emailprotected] or Nicole CarrilloExecutive Vice President, Chief Accounting Officer(949) 575-5187[emailprotected] Media Contact:Lori WildrickVice President, Communications(949) 330-8791[emailprotected] LDI-IR SOURCE loanDepot, Inc.

loanDepot Announces Fourth Quarter and Full Year 2020 Financial Results

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Codemasters Group Holdings plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 22nd January 2021 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 1p ordinary (GB00BFWZ2G72) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: - - - - (2) Cash-settled derivatives: 5,377,007 3.527% - - (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - - - - TOTAL: 5,377,007 3.527% - - All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP) GB00BFWZ2G72 Equity Swap Increasing a long position 77,269 6.02 GB00BFWZ2G72 Equity Swap Increasing a long position 341,929 6.01 GB00BFWZ2G72 Equity Swap Increasing a long position 500,000 6.01 GB00BFWZ2G72 Equity Swap Increasing a long position 1,000,000 6.01 GB00BFWZ2G72 Equity Swap Increasing a long position 85,490 6.01 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 25th January 2021 Contact name: Milos Naumovic Telephone number: +44 203 650 8203 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.

Form 8.3 - Codemasters Group Holdings plc

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) has agreed to the submission of an NDA based on data from Cohort 2 of its Phase 2 clinical trial, ZENITH20, which evaluated previously treated patients with non-small cell lung cancer (NSCLC) with HER2 exon 20 insertion mutations. The company also reported that its pre-specified primary endpoint in its Phase 2 clinical trial evaluating poziotinib in first-line NSCLC patients with EGFR exon 20 insertion mutations was not met in Cohort 3. Spectrum additionally reported that preliminary data from patients receiving 8 mg of poziotinib twice daily demonstrated meaningful improvement in tolerability as measured by adverse events and dosing interruptions. The agreement with the FDA to proceed with the submission of a new drug application is a significant milestone for the poziotinib program, said Joe Turgeon, President and CEO of Spectrum Pharmaceuticals. The improved tolerability from the BID dosing could have a meaningful impact on the overall safety and efficacy profile of poziotinib in an area of high unmet medical need. The company had a successful pre-NDA meeting with the FDA which resulted in an agreement to submit an NDA for poziotinib. During the meeting, Spectrum confirmed with the FDA that Cohort 2 data could serve as the basis of an NDA submission. The company will continue to work with the FDA as it prepares the application for submission in 2021. Cohort 2 enrolled 90 patients who received an oral once daily dose of 16 mg of poziotinib. The intent-to-treat analysis demonstrated a confirmed objective response rate (ORR) of 27.8% (95% Confidence Interval (CI), 18.9%-38.2%). The observed lower bound of 18.9% exceeded the pre-specified lower bound of 17%. The median duration of response was 5.1 months and the median progression free survival was 5.5 months. In this cohort, 87% of patients had drug interruptions with 11 patients (12%) permanently discontinuing due to adverse events. 13 patients (14%) had treatment-related serious adverse events. We are pleased that the FDA meeting confirmed that Cohort 2 data can serve as the basis of a NDA submission and our team is diligently working on preparing our file for submission in 2021, said Francois Lebel, M.D., Chief Medical Officer of Spectrum Pharmaceuticals. While Cohort 3 did not meet its pre-specified ORR endpoint, we are seeing evidence of clinical activity with a disease control rate (DCR) of 86% and progression free survival data of 7.2 months. Dr. Lebel added, The preliminary data from Cohort 5 with 8 mg twice daily dosing is supporting our hypothesis that this new dosing paradigm improves tolerability substantially, with Grade 3 adverse events reduced by about a third. We believe that improved tolerability and reduced drug dosing interruptions are key to patients staying on the drug longer and could potentially enhance anti-tumor effectiveness across the various EGFR and HER2 cohorts. These early findings, if confirmed, could benefit the entire poziotinib program. Cohort 3 of the ZENITH20 clinical trial enrolled a total of 79 patients who received an oral once daily dose of 16 mg of poziotinib. The median time of follow up of all patients was 9.2 months with 12 ongoing patients still on treatment. The intent-to-treat analysis showed that 22 patients had a partial response (by RECIST) and 68 patients had stable disease for an 86.1% DCR. 91% of patients experienced tumor reduction with a median reduction of 25.5%. The confirmed ORR was 27.8% (95% CI 18.4-39.1%). Based on the pre-specified statistical hypothesis for the primary endpoint, the observed lower bound of 18.4% did not meet the pre-specified lower bound of >20%. The median duration of response was 6.5 months and the median progression free survival was 7.2 months. The safety profile was similar with the type of adverse events observed with other second-generation EGFR tyrosine kinase inhibitors. Grade 3 treatment related rash was 33% and diarrhea was 23%. 94% of patients had drug interruptions with 6 patients (8%) permanently discontinuing due to adverse events. Preliminary data from Cohort 5 for patients with exon 20 insertion mutations receiving 8 mg twice daily dosing shows improved tolerability versus patients who received the 16 mg once daily dose. The data from this cohort includes patients with both EGFR and HER2 mutations. In Cycle 1, the incidence of Grade 3 or higher treatment related adverse events (rash, diarrhea and stomatitis) decreased by 32% for patients receiving the 8 mg twice daily dose. In addition, dose interruptions were reduced by 38% for the 8 mg twice daily dose versus the 16 mg once daily dose. No new types of adverse events were observed with the twice daily dosing regimen. Conference Call and Webcast The companys management will host a webcast and conference call today, December 22, 2020, at 4:30 p.m. ET / 1:30 p.m. PT. The live call may be accessed by dialing (877) 837-3910 for domestic callers and (973) 796-5077 for international callers and entering the conference ID#: 5036836. A live webcast of the call will be available from the Investor Relations section of the companys website at https://investor.sppirx.com/events-and-presentations and will be archived there shortly after the live event. About Poziotinib Poziotinib is a novel, oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) that inhibits the tyrosine kinase activity of EGFR as well as HER2 and HER4. Importantly this, in turn, leads to the inhibition of the proliferation of tumor cells that overexpress these receptors. Mutations or overexpression/amplification of EGFR family receptors have been associated with a number of different cancers, including non-small cell lung cancer (NSCLC), breast cancer, and gastric cancer. The company holds an exclusive license from Hanmi Pharmaceuticals to develop, manufacture, and commercialize poziotinib worldwide, excluding Korea and China. Poziotinib is currently being investigated by the company and Hanmi in several mid-stage trials in multiple solid tumor indications. About ZENITH20 The ZENITH20 trial is comprised of 7 independent cohorts. Cohorts 1 - 4 are each independently powered for a pre-specified statistical hypothesis with a primary endpoint of ORR. Cohorts 5 - 7 are exploratory. In December 2019, the company reported that the primary endpoint for Cohort 1 (EGFR) was not met but clinical activity was seen. Based on the results of Cohort 1, the company has amended the protocol for ZENITH20 to explore additional twice-daily dosing regimens as well as lower single daily dosage. In September 2020, the company reported that Cohort 2 met its primary endpoint. Cohorts 4 - 7 are still enrolling patients. About Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business model, from in-licensing and acquiring differentiated drugs, clinically developing novel assets, successfully gaining regulatory approvals and commercializing in a competitive healthcare marketplace. Spectrum has a late-stage pipeline with novel assets that serve areas of unmet need. This pipeline has the potential to transform the company in the near future. For additional information on Spectrum Pharmaceuticals, please visit www.sppirx.com. Notice Regarding Forward-Looking Statements Certain statements in this press release may constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, as amended to date. These forward-looking statements relate to a variety of matters, including, without limitation, statements that relate to the companys business and its future, including the significance of Cohort 3s reported results; the significance of the preliminary data from Cohort 5, including, but not limited to, whether the new dosing paradigm will continue to improve tolerability, lead to patients staying on the drug longer and enhance anti-tumor effectiveness and the impact of such data on the entire poziotinib program; the timing and outcome of filing an NDA with Cohort 2 data with the FDA; the overall determination of a path forward for poziotinib; poziotinibs potential to significantly advance the treatment of NSCLC patients with EGFR or HER2 exon 20 insertion mutations; the timing and result of future FDA approvals; the overall progression of the poziotinib development program; the companys ability to advance development of its late-stage pipeline assets and such assets ability to serve areas of unmet need; the potential of the companys existing drug pipeline to transform the company in the near future; and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations, and assumptions of the management of the company and are subject to significant risks and uncertainties that could cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. Risks that could cause actual results to differ include the possibility that the different methodologies, assumptions and applications the company utilizes to assess particular safety or efficacy parameters may yield different statistical results, and even if the company believes the data collected from the clinical trials of its product candidates, including poziotinib, are positive, these data may not be sufficient to support approval by the FDA; the possibility that success in early clinical trials, especially if based on a small patient sample, might not result in success in later clinical trials, and other unforeseen events during clinical trials which could cause delays or other adverse consequences; the companys existing and new drug candidates, including poziotinib, may not prove safe or effective; the possibility that the companys existing and new applications to the FDA and other regulatory agencies, including the NDA with Cohort 2 data it plans to submit in 2021, may not receive approval in a timely manner or at all; the possibility that the companys existing and new drug candidates, including poziotinib, if approved, may not be more effective, safer or more cost efficient than competing drugs; the possibility that the companys efforts to acquire or in-license and develop additional drug candidates may fail; the companys dependence on third parties for clinical trials, manufacturing, distribution and quality control and other risks that are described in further detail in the company's reports filed with the Securities and Exchange Commission (SEC). The company does not plan to update any such forward-looking statements and expressly disclaims any duty to update the information contained in this press release except as required by law. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of the company in general, see the risk disclosures in the companys Annual Report on Form 10-K for the year ended December 31, 2019, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by the company. SPECTRUM PHARMACEUTICALS, INC. and ROLONTIS are registered trademarks of Spectrum Pharmaceuticals, Inc. and its affiliates. REDEFINING CANCER CARE and the Spectrum Pharmaceuticals logos are trademarks owned by Spectrum Pharmaceuticals, Inc. Any other trademarks are the property of their respective owners. 2020 Spectrum Pharmaceuticals, Inc. All Rights Reserved

Spectrum Provides Poziotinib Update after Successful Pre-NDA Meeting with the FDA FDA agrees to the submission of an NDA for poziotinib for non-small cell lung cancer (NSCLC) in previously treated patients with HER2 exon 20 insertion mutations, NDA submission planned for 2021 Cohort 3 of the ZENITH20 clinical trial, which enrolled first-line NSCLC patients with EGFR exon 20 insertion mutations at 16mg once daily, did not meet its primary endpoint Preliminary data from 8 mg twice daily dosing demonstrates meaningful improvement in tolerability Management to host webcast and conference call today at 4:30 p.m. ET / 1:30 p.m. PT

BUFORD, Ga., Oct. 28, 2020 /PRNewswire/ --Radial, a bpost group company, the leader in omnichannel commerce technology and operations, today announced its plan to bring on more than 350entry-level fulfillment center workers in Buford, Georgia, to support unprecedented ecommerce demand this holiday season. Seasonal workers will be responsible for processing online orders - including picking, sorting, packing and shipping - all in a fun team environment leveraging cutting-edge technology. Consumer researchreveals that 66% of shoppers plan to increase their online purchases during the holidays this year. As ecommerce demand reaches new heights in the wake of the COVID-19 pandemic, retailers must significantly scale their fulfillment workforce to meet holiday shopping needs. With 20+ fulfillment centers and a global fulfillment and transportation network, Radial is well-versed at helping retailers successfully navigate peak shopping season while keeping worker safety at the forefront. In response to the COVID-19 pandemic, Radial remains committed to safety and has made it a priority to implement processes and technologies to maintain the health and safety of every worker. These initiatives include: Implementing automated temperature thermal screenings for anyone prior to entering every facility, visitors included Requirements to wear masks at all times Adjustments to working layouts and technology enhancements to enable and enforce social distancing Instant-Trace badges to remind and train new hires on social distancing best practices Heightened hygiene and sanitation procedures across every site to reduce risk "The health and safety of our employees is Radial's number one priority," said Eric Wohl, Chief Human Resources Officer, and Senior Vice President. "We've always prided ourselves on our people-first approach, and we've built a culture where coworkers feel like family. This close-knit community is part of what historically has made us so successful at achieving peak season goals for our clients. When demand increases, our people work together to rise to the challenge. Our people-first workplace has been tested since COVID-19 hit, and I am deeply proud of how we've evolved our working environment to keep our strong community values intact while deepening safety measures. At Radial, we know we all have a role to play in following safety precautions, and everyone looks out for each other so we help keep our workplaces and communities safe." Seasonal workers at the Buford location will enjoy benefits including competitive hourly wages and opportunities for overtime. Additionally, Radial leverages leading fulfillment technologies to enable new associates to safely and quickly learn job processes. These seasonal roles are a great opportunity to kickstart a career with Radial. Seasonal workers will join the more than 3,000 regular, full-time employees at Radial's fulfillment centers across the country to help pack and ship holiday orders. For individuals seeking long-term employment, Radial plans to offer significant opportunities to convert into full-time positions this year to support Radial's strong growth. There will be opportunities for local residents who worked in industries impacted by the pandemic such as retail storefronts, restaurants, and hospitality to switch career paths, and leverage transferable skills within the fulfillment centers. Radial is actively accepting seasonal candidates from all backgrounds. At the fulfillment center in Buford, Georgia, seasonal workers will have the chance to work with some of the world's favorite brands and retailers. Workers will source orders and send them to their final destinations faster using Radial's technology, fulfillment, and transportation solutions. To learn more about Radial's seasonal job openings in Buford, Georgia, visit Radial's career page. About RadialRadial, Inc., a bpost group company, is the leader in omnichannel commerce technology and operations. Premier brands around the world confidently partner with Radial to deliver their brand promises, anticipate and respond to industry disruption, and compete in a rapidly evolving market. Radial's innovative solutions connect retailers and customers through advanced omnichannel technologies; intelligent payments and fraud protection; efficient fulfillment, supply chain services; and insightful customer care services especially where high-value customer experiences are critical. We are flexible, scalable, and focused on our clients' business objectives. Learn how we deliver today's retail for you at radial.com and follow us on Twitter @radialcorp. Press Contact for Radial:Laura Beauregard[emailprotected]407-734-7320 SOURCE Radial Related Links https://www.radial.com/

Radial Hiring for More Than 350 Seasonal Fulfillment Jobs in Buford, Georgia to Support Upcoming Holiday Rush Radial prioritizes safe working conditions with anticipated holiday ecommerce surge

LOS ANGELES--(BUSINESS WIRE)--BIGtoken, Inc., the first privacy focused, opt-in data marketplace where people can own and monetize their data, publishes a monthly report on the top 10 stories in data and crypto privacy. The government plays a critical role in protecting privacy rights through the enactment of laws and regulations governing the collection and use of personal data. The support for passage of these laws continues to grow albeit at a slower pace than many would hope. 1. Comprehensive Data Privacy Law Bring Big Changes To Virginia, But Excludes Personal Employee Data, The National Law Review - April 7, 2021 2. Colorado Mulls New Data Privacy Bill, ExchangeWire - April 6, 2021 3. Data Privacy Bill Easily Clears House, Florida Politics - April 21, 2021 4. Big Tech Is Pushing States To Pass Privacy Laws, And Yes, You Should Be Suspicious, The Nextweb - April 19, 2021 As rules and regulations continue to move forward, the balance between the benefits and potential harm concerning the collection and use of personal data continues to be exposed and debated. Further, as the data privacy issue becomes more understood, concerns about its misuse in areas such as personal financial information has become increasingly heightened. 5. Increase In Digital Banking Raises Consumer Data Privacy Concerns: How To Protect Yourself, Forbes - April 5, 2021 6. Facebook Is Under Investigation In The EU For Its Massive Leak Of 533 Million Peoples Data And It Could Face A Fine In The Billions, Business Insider - April 14, 2021 7. WhatsApp Privacy Policys May 15 Deadline: With A Month Left, What You Need To Keep In Mind, MSN - April 15, 2021 8. Personal Data And Privacy: Social Media Users Must Realize Theres Always A Price To Pay For Free Apps, MSN - April 20, 2021 More and more, there is a focus on how blockchain technology can improve data privacy and security in areas including cryptocurrency, payment processing and non-fungible tokens (NFTs). There is no question that blockchain technology will become critical in all industries and every aspect of life. 9. The Challenges of Private Blockchain Transactions, Nasdaq April 9, 2021 10. Institutions Begin to Implement Innovative Functions of Blockchain Technology, PR Newswire April 26, 2021 11. Dtsocialize The New Blockchain Concept for Privacy Protection, Yahoo April 21, 2021 About BIGtoken BIGtoken is the first privacy focused, opt-in data marketplace where people can own and monetize their data. Through a transparent platform and consumer reward system, BIG offers users choice, transparency, and compensation for their anonymized data. Participating consumers earn rewards and advertisers and media companies get access to insights from compliant first-party data for marketing and media activation. BIGtoken believes that data privacy is a human right. For more information on BIGtoken, visit bigtoken.com. Cautionary Statement Regarding Forward-Looking Information: This news release contains "forward-looking statements'' made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to future, not past, events and may often be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "seek" or "will." Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Specific risks and uncertainties that could cause our actual results to differ materially from those expressed in our forward-looking statements include risks inherent in our business, and our need for future capital. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in BIGtokens periodic reports filed with the Securities and Exchange Commission (SEC). We do not assume any obligation to update any forward-looking statements.

BIGtokens Top 10 Privacy and Crypto Headlines From April 2021

DUBLIN, Dec. 3, 2020 /PRNewswire/ -- The "Increasing Adoption of Low-cost Devices with Simple Designs in Response to COVID-19 to Disrupt the US & EU-5 Ventilator Market, 2025" report has been added to ResearchAndMarkets.com's offering. Revenue for the US & EU-5 ventilators market is expected to increase by 370.7% in 2020 driven by the ongoing Coronavirus 2019 (COVID-19) situation. The home care segment is expected to see a comparatively strong growth potential post-pandemic. This study assesses the revenue growth impact on different ventilator market segments. It also analyzes future growth opportunities for industry participants in light of the following strategic imperatives - geopolitical chaos due to the pandemic situation and the increasing number of critical care patient admits requiring ventilator use; adoption of disruptive technologies for ventilator designs and assistive technologies; and increasing competition due to the widening demand-supply gap and relaxed regulations. Further, this study provides an evaluation of 9 different growth opportunities from the perspectives of supply chain optimization, technology focus, vertical expansion, customer and branding, new product development and others. Supply chain disruption, excess of low-cost and sub-standard ventilators, and shortage of trained healthcare staff are seen as key market restraints. Three examples of key growth opportunities evaluated are: Remote ventilator surveillance for better care management Strategic geographic expansion for improving market access Targeted brand positioning for improved market penetration Key Topics Covered: Strategic Imperatives Why Is It Increasingly Difficult to Grow? The Strategic Imperative The Impact of the Top Three Strategic Imperatives on the Ventilators Industry Key Questions this Study will Answer Growth Opportunities Fuel the Growth Pipeline Engine Growth Opportunity Analysis, Ventilators Scope of Analysis Ventilator Market Segmentation Key Competitors, Ventilators Key Growth Metrics for Ventilators Distribution Channels for Ventilators Growth Drivers for Ventilators Growth Restraints for Ventilators Forecast Assumptions, Ventilators Revenue and Unit Shipment Forecast, Ventilators Revenue Forecast by Site of Care, Ventilators Revenue Forecast by Region, Ventilators Revenue Distribution by Region, Ventilators Revenue Forecast Analysis, Ventilators Revenue Forecast Analysis by Site of Care, Ventilators Unit Shipment Forecast by Site of Care, Ventilators Unit Shipment Forecast by Region, Ventilators Unit Shipment Forecast Analysis, Ventilators Pricing Trends and Forecast Analysis, Ventilators Innovation Trend Analysis, Ventilator Market Regulatory & Reimbursement Environment Competitive Environment, Ventilators Revenue Share, Ventilators Revenue Share Analysis, Ventilators Growth Opportunity Analysis, Ventilators in Acute Care (Adult) Key Growth Metrics for Ventilators in Acute Care (Adult) Revenue and Unit Shipment Forecast, Ventilators in Acute Care (Adult) Revenue Forecast by Region, Ventilators in Acute Care (Adult) Unit Shipment Forecast by Region, Ventilators in Acute Care (Adult) Forecast Analysis, Ventilators in Acute Care (Adult) Growth Opportunity Analysis, Ventilators in Acute Care (Neonatal) Key Growth Metrics for Ventilators in Acute Care (Neonatal) Revenue and Unit Shipment Forecast, Ventilators in Acute Care (Neonatal) Revenue Forecast by Region, Ventilators in Acute Care (Neonatal) Unit Shipment Forecast by Region, Ventilators in Acute Care (Neonatal) Forecast Analysis, Ventilators in Acute Care (Neonatal) Growth Opportunity Analysis, Ventilators in Long-Term Acute Care (LTAC) Key Growth Metrics for Ventilators in Long-Term Acute Care Revenue and Unit Shipment Forecast, Ventilators in Long-Term Acute Care Revenue Forecast by Region, Ventilators in Long-Term Acute Care Unit Shipment Forecast by Region, Ventilators in Long-Term Acute Care Forecast Analysis, Ventilators in Long-Term Acute Care Growth Opportunity Analysis, Ventilators in Sub-Acute Care Key Growth Metrics for Ventilators in Sub-Acute Care Revenue and Unit Shipment Forecast, Ventilators in Sub-Acute Care Revenue Forecast by Region, Ventilators in Sub-Acute Care Unit Shipment Forecast by Region, Ventilators in Sub-Acute Care Forecast Analysis, Ventilators in Sub-Acute Care Growth Opportunity Analysis, Ventilators in Transport/Emergency Care Key Growth Metrics for Ventilators in Transport/Emergency Care Revenue and Unit Shipment Forecast, Ventilators in Transport/ Emergency Care Revenue Forecast by Region, Ventilators in Transport/Emergency Care Unit Shipment Forecast by Region, Ventilators in Transport/Emergency Care Forecast Analysis, Ventilators in Transport/Emergency Care Growth Opportunity Analysis, Ventilators in Home Care Key Growth Metrics for Ventilators in Home Care Revenue and Unit Shipment Forecast, Ventilators in Home Care Revenue Forecast by Region, Ventilators in Home Care Unit Shipment Forecast by Region, Ventilators in Home Care Forecast Analysis, Ventilators in Home Care Growth Opportunity Universe, Ventilator Equipment Market Growth Opportunity Universe Background Growth Opportunities Aligned to Timeframe & Growth Potential Growth Opportunity 1-Strategic Manufacturing Expansion for Fulfilling COVID-19 Demand Growth Opportunity 2-Remote Ventilator Surveillance for Better Care Management Growth Opportunity 3-Supply Chain & Distribution Optimization Growth Opportunity 4-Training for Addressing Clinical Variations Growth Opportunity 5-Strategic Geographic Expansion for Improving Market Access Growth Opportunity 6-Smart Ventilation for Better Care Management Growth Opportunity 7-Advanced Solutions for Ventilator Associated Events Growth Opportunity 8-Targeted Brand Positioning for Improved Market Penetration Growth Opportunity 9-Home Care Segment to Present Strong Growth Potential Appendix For more information about this report visit https://www.researchandmarkets.com/r/56o0h0 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

United States & EU-5 Ventilator Market Report 2020-2025: Rising Preference for Home-based Care, Aided by Remote Monitoring Technologies, to Drive New Growth Opportunities

NEW YORK--(BUSINESS WIRE)--The Central and Eastern Europe Fund, Inc. (NYSE: CEE), The New Germany Fund, Inc. (NYSE: GF) and The European Equity Fund, Inc. (NYSE: EEA) (each, a Fund, and collectively, the Funds) each announced today that its Board of Directors declared the distributions set forth below. CEEs and GFs total distributions will be paid in stock except that any stockholder of record as of December 30, 2020 may elect to receive such distribution in cash. Details for each Funds 2020 yearly December distributions are as follows: Declaration- 12/18/2020 Ex-Date- 12/29/2020 Record- 12/30/2020 Payable- 1/28/2021 Ticker Net Investment Short-Term Long-Term Total Income per Share Capital Gains per Share Capital Gains per Share Distribution per Share The Central and Eastern Europe Fund, Inc. CEE $0.9188 $0.0000 $0.0000 $0.9188 The New Germany Fund, Inc. GF $0.0000 $0.2592 $1.8598 $2.1190 The European Equity Fund, Inc. EEA $0.0694 $0.0000 $0.0000 $0.0694 For more information on each Fund, including the most recent month-end performance, visit www.dwsfunds.com or call (800) 349-4281. The European Equity Fund, Inc. and The New Germany Fund, Inc. Investing in foreign securities, particularly of emerging markets, presents certain risks, such as currency fluctuations, political and economic changes, and market risks. Any fund that concentrates in a particular segment of the market or a particular geographical region will generally be more volatile than a fund that invests more broadly. The Central and Eastern Europe Fund, Inc. Investing in foreign securities presents certain risks, such as currency fluctuations, political and economic changes, and market risks. Emerging markets tend to be more volatile and less liquid than the markets of more mature economies, and generally have less diverse and less mature economic structures and less stable political systems than those of developed countries. Any fund that focuses in a particular segment of the market or region of the world will generally be more volatile than a fund that invests more broadly. This fund is non-diversified and can take larger positions in fewer issues, increasing its potential risk. The shares of most closed-end funds, including the Funds, are not continuously offered. Once issued, shares of closed-end funds are bought and sold in the open market through a stock exchange. Shares of closed-end funds frequently trade at a discount to net asset value. The price of a funds shares is determined by a number of factors, several of which are beyond the control of the fund. Therefore, a fund cannot predict whether its shares will trade at, below, or above net asset value. Investments in funds involve risk. Additional risks of the Funds are associated with international investing, such as currency fluctuations, political and economic changes, market risks, government regulations and differences in liquidity, which may increase the volatility of your investment. Foreign security markets generally exhibit greater price volatility and are less liquid than the US market. Additionally, the Funds focus their investments in certain geographical regions, thereby increasing their vulnerability to developments in that region and potentially subjecting the Funds shares to greater price volatility. Some funds have more risk than others. These include funds, such as the Funds, that allow exposure to or otherwise concentrate investments in certain sectors, geographic regions, security types, market capitalization, or foreign securities (e.g., political or economic instability, which can be accentuated in emerging market countries). The European Union, the United States and other countries have imposed sanctions on Russia in response to Russian military and other actions in recent years. These sanctions have adversely affected Russian individuals, issuers and the Russian economy. Russia, in turn, has imposed sanctions targeting Western individuals, businesses and products. The various sanctions have adversely affected, and may continue to adversely affect, not only the Russian economy, but also the economies of many countries in Europe, including countries in Central and Eastern Europe. The continuation of current sanctions or the imposition of additional sanctions may materially adversely affect the value of the Funds portfolios. Past performance is no guarantee of future results. This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction. War, terrorism, economic uncertainty, trade disputes, public health crises (including the recent pandemic spread of the novel coronavirus) and related geopolitical events could lead to increased market volatility, disruption to US and world economies and markets and may have significant adverse effects on the fund and their investments. NOT FDIC/ NCUA INSURED MAY LOSE VALUE NO BANK GUARANTEE NOT A DEPOSIT NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY DWS Distributors, Inc. 222 South Riverside Plaza Chicago, IL 60606-5808 www.dws.com Tel (800) 621-1148 2020 DWS Group GmbH & Co. KGaA. All rights reserved The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas, Inc. and RREEF America L.L.C. which offer advisory services. (R-080411-1) (12/20)

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

BOSTON--(BUSINESS WIRE)--Cyber Monday Dyson deals for 2020 are underway. Review the best savings on Dyson hair dryers, fan heaters & vacuums Browse the full selection of deals using the links below. Best Dyson Deals: Best Dyson vacuum deals: Best Dyson Animal Deals: Best Dyson Absolute Deals: Best Dyson Purifier Deals: Best Dyson Fan Heater Deals: Searching for more deals? Check out Walmarts Cyber Monday sale and Amazons Cyber Monday sale to view thousands more live savings. Spending Lab earns commissions from purchases made using the links provided. About Spending Lab: Spending Lab research and report on online sales events. As an Amazon Associate and affiliate Spending Lab earns from qualifying purchases.

Dyson Cyber Monday Deals 2020: Vacuum, Purifier, Fan Heater & More Sales Revealed by Spending Lab Cyber Monday Dyson deals are underway, find all the top Cyber Monday Dyson cordless vacuum cleaner, purifiers & more deals right here on this page

ATLANTA, Feb.3, 2021 /PRNewswire/ -- Q3 Fiscal Year 2021 Highlights Net income from continuing operations of $195 million, up 82% YoY; excluding special items, net income of $209 million Shipments of 933 kilotonnes, up 17% YoY Adjusted EBITDA of $501 million, up 46% YoY Adjusted EBITDA per ton of $537, up 25% YoY Focus on deleveraging resulted in net leverage ratio improvement to 3.3x from 3.8x at acquisition close Integration work continues with $54 million run-rate acquisition cost synergies achieved through end of Q3 Novelis Inc., the world leader in aluminum rolling and recycling, today reported a net income attributable to its common shareholder of $176 million in the third quarter of fiscal year 2021, and net income from continuing operations of $195 million, up 64 percent and 82 percent, respectively, versus the prior year. Excluding tax-effected special items in both years, third quarter fiscal 2021 net income was a record high $209 million, up 58 percent versus the prior year period, driven mainly by higher after-tax Adjusted EBITDA, partially offset by higher depreciation and amortization associated with the acquisition of Aleris. Adjusted EBITDA increased 46 percent to $501 million in the third quarter of fiscal 2021 compared to $343 million in the prior year period. The increase in Adjusted EBITDA is due to organic growth, favorable metal benefits, and a net $50 million positive EBITDA contribution from the acquired Aleris business. The current quarter also includes a positive $25 million from a year-to-date customer contractual obligation. On a consolidated basis, Novelis achieved a record EBITDA per ton shipped of $537 in the third quarter, compared to $430 in the prior year. Net sales increased 19 percent from the prior year period to $3.2 billion for the third quarter of fiscal 2021, primarily driven by a seventeen percent increase in total shipments and higher average aluminum prices. Total flat rolled product shipments increased to 933 kilotonnes, mainly reflecting the addition of the acquired Aleris business and strong demand across product end markets, particularly beverage can. "Novelis achieved record financial performance in the third quarter based on continued demand for innovative, sustainable aluminum solutions and outstanding operational performance across our expanded business," said Steve Fisher, President and CEO, Novelis Inc. "We are also making excellent progress on our strategic growth initiatives to drive long term value, by investing in new capacity and technology, entering new partnerships to solidify aluminum as the material of choice for our customers, and bringing new alloys to market that will drive the industry forward." Year-to-date fiscal 2021 free cash flow from continuing operations of $331 million compares to $61 million in the prior year period, driven primarily by higher Adjusted EBITDA, favorable working capital and lower capital expenditures. Capital expenditures of $333 million are down 23% versus the prior year as spending is prioritized to support maintenance activities and organic, strategic capacity projects underway. The greenfield Guthrie, Kentucky, automotive finishing plant in the U.S. shipped its first customer coils in December, while the new automotive finishing line in Changzhou, China, is expected to start commercial production in the fourth quarter this fiscal year. The recycling, casting and rolling expansion in Brazil remains on track to commission in the middle of fiscal year 2022. Nine Months Ended December31, (in $ millions, non-GAAP measures) 2020 2019 Free cash flow from continuing operations $ 331 $ 61 Capital expenditures 333 430 Free cash flow from continuing operations before capital expenditures $ 664 $ 491 Net leverage improved during the quarter to 3.3x, compared to 3.8x at the close of the Aleris acquisition in the first quarter fiscal 2021. This reduction is a factor of both stronger Adjusted EBITDA, as well as a $500 million reduction in the Company's short term bridge loan due 2022. "We are delivering on our commitments to improve net leverage through debt reduction resulting from strong cash flow generation," said Devinder Ahuja, Senior Vice President and Chief Financial Officer, Novelis Inc. "With a favorable demand outlook, robust acquisition synergy savings, and prioritized capital spending, we now anticipate achieving our targeted net leverage level of below 3x earlier than the end of fiscal year 2022 as previously guided." The company continues to maintain a very strong total liquidity position of $2.4 billion as of December31, 2020. COVID-19 ResponseNovelis' primary focus remains the health and well-being of its employees. The company is closely monitoring the changing landscape with respect to the COVID-19 pandemic and taking actions to manage its business and support customers. Novelis has bolstered its Environmental Health and Safety protocols to align with guidance from global health authorities and government agencies across company operations to help ensure the safety of its employees, customers, suppliers, communities and other stakeholders. Customer demand has recovered to pre-COVID levels in most end markets, and Novelis will continue to work closely with customers to leverage its global manufacturing footprint and adjust production levels to meet their needs. Update on Aleris Acquisition, Integration and Required DivestmentsOn April 14, 2020, Novelis closed its acquisition of Aleris Corporation and is integrating the two companies to drive a number of strategic benefits and allow for at least $180 million in potential annual synergies. The results from continuing operations reported today for the period ending December 31, 2020 reflect the acquired businesses. Results related to the Duffel and Lewisport plants are reflected as results from discontinued operations. The company filed a form 8-K/A with the Securities and Exchange Commission on June 30, 2020, providing historical and pro forma financial information related to the acquisition. On November 30, 2020, Novelis completed the required divestment of the Lewisport automotive body sheet business to American Industrial Partners, a private equity firm. Upon closing, Novelis received $180 million in cash proceeds. The required divestment of the Duffel plant was previously completed in September, 2020. With divestments now complete, Novelis is focusing on the safe integration of the continuing operations to drive value creation. Novelis' acquisition of Aleris provides a strong pro-forma financial profile, many strategic benefits, namely securing an integrated manufacturing footprint in China, further portfolio diversification with the addition of aerospace and building and construction, well as new technology and operational capabilities. Third Quarter of Fiscal Year 2021 Earnings Conference Call Novelis will discuss its third quarter of fiscal year 2021 results via a live webcast and conference call for investors at 7:30 a.m. ET on Wednesday, February3, 2021. To view slides and listen only, visit https://cc.callinfo.com/r/1rx5pyo03mq8y&eom. To join by telephone, dial toll-free in North America at 800-954-0592, India toll-free at 18002662120 or the international toll line at +1-303-223-0120. Presentation materials and access information may also be found at novelis.com/investors. About NovelisNovelis Inc. is driven by its purpose to shape a sustainable world together. As a global leader in innovative products and services and the world's largest recycler of aluminum, we partner with customers in the aerospace, automotive, beverage can and specialties industries to deliver solutions that maximize the benefits of lightweight aluminum throughout North America, Europe, Asia and South America. Novelis is a subsidiary of Hindalco Industries Limited, an industry leader in aluminum and copper, and the metals flagship company of the Aditya Birla Group, a multinational conglomerate based in Mumbai, India. For more information, visit novelis.com. Non-GAAP Financial MeasuresThis news release and the presentation slides for the earnings call contain non-GAAP financial measures as defined by SEC rules. We believe these measures are helpful to investors in measuring our financial performance and liquidity and comparing our performance to our peers. However, our non-GAAP financial measures may not be comparable to similarly titled non-GAAP financial measures used by other companies. These non-GAAP financial measures have limitations as an analytical tool and should not be considered in isolation or as a substitute for GAAP financial measures. To the extent we discuss any non-GAAP financial measures on the earnings call, a reconciliation of each measure to the most directly comparable GAAP measure will be available in the presentation slides filed as Exhibit 99.2 to our Current Report on Form 8-K furnished to the SEC concurrently with the issuance of this press release. In addition, the Form 8-K includes a more detailed description of each of these non-GAAP financial measures, together with a discussion of the usefulness and purpose of such measures. Attached to this news release are tables showing the Condensed Consolidated Statements of Operations, Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Cash Flows, Reconciliation to Adjusted EBITDA, Free Cash Flow, Liquidity, Net Income from continuing operations excluding Special Items, and Segment Information. Forward-Looking Statements Statements made in this news release which describe Novelis' intentions, expectations, beliefs or predictions may be forward-looking statements within the meaning of securities laws.Forward-looking statements include statements preceded by, followed by, or including the words "believes," "expects," "anticipates," "plans," "estimates," "projects," "forecasts," or similar expressions.Examples of forward looking statements in this news release are statements about our ability to reduce net leverage and total debt, expected results from our strategic growth initiatives, adjustments to production to meet customer needs, expected start dates of new facilities, and potential acquisition synergies from our acquisition of Aleris. Novelis cautions that, by their nature, forward-looking statements involve risk and uncertainty and Novelis' actual results could differ materially from those expressed or implied in such statements.We do not intend, and we disclaim any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.Factors that could cause actual results or outcomes to differ from the results expressed or implied by forward-looking statements include, among other things: changes in the prices and availability of aluminum (or premiums associated with such prices) or other materials and raw materials we use; the capacity and effectiveness of our hedging activities; relationships with, and financial and operating conditions of, our customers, suppliers and other stakeholders; fluctuations in the supply of, and prices for, energy in the areas in which we maintain production facilities; our ability to access financing including in connection with potential acquisitions and investments; risks arising out of our acquisition of Aleris Corporation, including risks inherent in the acquisition method of accounting; disruption to our global aluminum production and supply chain as a result of COVID-19; changes in the relative values of various currencies and the effectiveness of our currency hedging activities; factors affecting our operations, such as litigation, environmental remediation and clean-up costs, breakdown of equipment and other events; economic, regulatory and political factors within the countries in which we operate or sell our products, including changes in duties or tariffs; competition from other aluminum rolled products producers as well as from substitute materials such as steel, glass, plastic and composite materials; changes in general economic conditions including deterioration in the global economy; changes in government regulations, particularly those affecting taxes, derivative instruments, environmental, health or safety compliance; changes in interest rates that have the effect of increasing the amounts we pay under our credit facilities and other financing agreements; and our ability to generate cash. The above list of factors is not exhaustive.Other important risk factors are included under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended March 31, 2020. Novelis Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Three Months Ended December31, Nine Months Ended December31, (in millions) 2020 2019 2020 2019 Net sales $ 3,241 $ 2,715 $ 8,645 $ 8,491 Cost of goods sold (exclusive of depreciation and amortization) 2,578 2,239 7,063 7,001 Selling, general and administrative expenses 149 131 400 380 Depreciation and amortization 137 91 396 267 Interest expense and amortization of debt issuance costs 66 59 206 185 Research and development expenses 20 21 57 58 Restructuring and impairment, net 20 3 28 36 Equity in net loss of non-consolidated affiliates 3 1 1 1 Business acquisition and other integration related costs 17 11 46 Other (income) expenses, net (7) (3) 86 3 $ 2,966 $ 2,559 $ 8,248 $ 7,977 Income from continuing operations before income tax provision 275 156 397 514 Income tax provision 80 49 119 157 Net income from continuing operations $ 195 $ 107 $ 278 $ 357 Loss from discontinued operations, net of tax (18) (47) Loss on sale of discontinued operations, net of tax (170) Net loss from discontinued operations (18) (217) Net income $ 177 $ 107 $ 61 $ 357 Net income attributable to noncontrolling interest 1 1 Net income attributable to our common shareholder $ 176 $ 107 $ 60 $ 357 Novelis Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (in millions, except number of shares) December 31, 2020 March 31,2020 ASSETS Current assets: Cash and cash equivalents $ 1,164 $ 2,392 Accounts receivable, net third parties (net of allowance for uncollectible accounts of $8 as of December31, 2020 andMarch 31, 2020) 1,556 1,067 related parties 185 164 Inventories 1,791 1,409 Prepaid expenses and other current assets 185 145 Fair value of derivative instruments 146 202 Assets held for sale 5 5 Current assets of discontinued operations 11 Total current assets $ 5,043 $ 5,384 Property, plant and equipment, net 4,732 3,580 Goodwill 1,065 607 Intangible assets, net 718 299 Investment in and advances to nonconsolidated affiliates 858 760 Deferred income tax assets 185 140 Other longterm assets third parties 358 219 related parties 1 Total assets $ 12,960 $ 10,989 LIABILITIES AND SHAREHOLDER'S EQUITY Current liabilities: Current portion of longterm debt $ 59 $ 19 Shortterm borrowings 151 176 Accounts payable third parties 2,097 1,732 related parties 252 176 Fair value of derivative instruments 183 214 Accrued expenses and other current liabilities 625 613 Current liabilities of discontinued operations 14 Total current liabilities $ 3,381 $ 2,930 Longterm debt, net of current portion 6,295 5,345 Deferred income tax liabilities 152 194 Accrued postretirement benefits 1,056 930 Other longterm liabilities 296 229 Total liabilities $ 11,180 $ 9,628 Commitments and contingencies Shareholder's equity Common stock, no par value; unlimited number of shares authorized; 1,000 shares issued andoutstanding as of December31, 2020 and March 31, 2020 Additional paidin capital 1,404 1,404 Retained earnings 688 628 Accumulated other comprehensive loss (266) (620) Total equity of our common shareholder $ 1,826 $ 1,412 Noncontrolling interest (46) (51) Total equity $ 1,780 $ 1,361 Total liabilities and equity $ 12,960 $ 10,989 Novelis Inc. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Nine Months Ended December31, (in millions) 2020 2019 OPERATING ACTIVITIES Net income $ 61 $ 357 Net loss from discontinued operations (217) Net income from continuing operations $ 278 $ 357 Adjustments to determine net cash provided by operating activities: Depreciation and amortization 396 267 Gain on unrealized derivatives and other realized derivatives in investing activities, net (8) (32) Gain on sale of assets (1) Impairment charges 13 Deferred income taxes, net 1 30 Equity in net loss of non-consolidated affiliates 1 1 Gain on foreign exchange remeasurement of debt (2) Amortization of debt issuance costs and carrying value adjustments 21 14 Other, net 2 Changes in assets and liabilities including assets and liabilities held for sale (net of effects fromdivestitures): Accounts receivable (174) 143 Inventories 83 (42) Accounts payable 154 (168) Other assets 68 (3) Other liabilities (170) (109) Net cash provided by operating activities - continuing operations 648 472 Net cash used in operating activities - discontinued operations (78) Net cash provided by operating activities $ 570 $ 472 INVESTING ACTIVITIES Capital expenditures (333) (430) Acquisition of business, net of cash acquired (2,614) Proceeds from sales of assets, third party, net of transaction fees and hedging 4 3 Proceeds from investment in and advances to non-consolidated affiliates, net 10 6 (Outflows) proceeds from the settlement of derivative instruments, net (3) 3 Other 9 10 Net cash used in investing activities - continuing operations (2,927) (408) Net cash provided by investing activities - discontinued operations 357 Net cash used in investing activities $ (2,570) $ (408) FINANCING ACTIVITIES Proceeds from issuance of long-term and short-term borrowings 1,972 79 Principal payments of long-term and short-term borrowings (589) (16) Revolving credit facilities and other, net (609) (38) Debt issuance costs (25) (3) Contingent consideration paid in acquisition of business (9) Net cash provided by financing activities - continuing operations 740 22 Net cash used in financing activities - discontinued operations (2) Net cash provided by financing activities $ 738 $ 22 Net (decrease) increase in cash, cash equivalents and restricted cash (1,262) 86 Effect of exchange rate changes on cash 53 (4) Cash, cash equivalents and restricted cash beginning of period 2,402 960 Cash, cash equivalents and restricted cash end of period $ 1,193 $ 1,042 Cash and cash equivalents $ 1,164 $ 1,031 Restricted cash (Included in "Other long-term assets") 15 11 Restricted cash (Included in "Prepaid expenses and other current assets") 14 Cash, cash equivalents and restricted cash end of period $ 1,193 $ 1,042 Reconciliation of Adjusted EBITDA (unaudited) to Net income attributable to our common shareholder The following table reconciles Adjusted EBITDA, a non-GAAP financial measure, to Net income attributable to ourcommon shareholder. Three Months Ended December31, Nine Months Ended December31, (in millions) 2020 2019 2020 2019 Net income attributable to our common shareholder $ 176 $ 107 $ 60 $ 357 Net income attributable to noncontrolling interests 1 1 Income tax provision 80 49 119 157 Interest, net 63 57 199 177 Depreciation and amortization 137 91 396 267 EBITDA $ 457 $ 304 $ 775 $ 958 Adjustment to reconcile proportional consolidation 13 13 42 42 Unrealized (gains) losses on change in fair value of derivative instruments, net (13) (6) 14 (15) Realized (gains) losses on derivative instruments not included in segment income (2) (1) 2 2 Restructuring and impairment, net 20 3 28 36 Loss (gain) on sale of fixed assets 2 1 (1) Purchase price accounting adjustments 29 Loss from discontinued operations, net of tax 18 47 Loss on sale of discontinued operations, net of tax 170 Metal price lag 11 32 18 Business acquisition and other integration related costs 17 11 46 Other, net 6 1 59 3 Adjusted EBITDA $ 501 $ 343 $ 1,209 $ 1,089 Free Cash Flow (unaudited) The following table reconciles Free cash flow, a non-GAAP financial measure, to Net cash provided by operatingactivities - continuing operations. Nine Months Ended December31, (in millions) 2020 2019 Net cash provided by operating activities - continuing operations $ 648 $ 472 Net cash used in investing activities - continuing operations (2,927) (408) Plus: Cash used in the acquisition of assets under a capital lease Plus: Cash used in the acquisition of business, net of cash and restricted cash acquired 2,614 Less: Proceeds from sales of assets and business, net of transaction fees, cash income taxes and hedging (4) (3) Free cash flow from continuing operations 331 61 Net cash used in operating activities - discontinued operations (78) Net cash provided by investing activities - discontinued operations 357 Less: Proceeds from sales of assets and business, net of transaction fees, cash income taxesand hedging - discontinued operations (403) Free cash flow $ 207 $ 61 Cash and Cash Equivalents and Total Liquidity (unaudited) The following table reconciles Total liquidity to the ending balances of cash and cash equivalents. (in millions) December 31, 2020 March 31,2020 Cash and cash equivalents $ 1,164 $ 2,392 Availability under committed credit facilities 1,226 186 Total liquidity $ 2,390 $ 2,578 Reconciliation of Net income from continuing operations, excluding special items (unaudited) to Net incomefrom continuing operations The following table presents Net income from continuing operations excluding special items. We adjust for itemswhich may recur in varying magnitude which affect the comparability of the operational results of our underlyingbusiness. Three Months Ended December31, Nine Months Ended December31, (in millions) 2020 2019 2020 2019 Net income from continuing operations 195 107 278 357 Special Items: Business acquisition and other integration related costs 17 11 46 Metal price lag 11 32 18 Restructuring and impairment, net 20 3 28 36 Charitable donation 50 Purchase price accounting adjustment 29 Tax effect on special items (6) (6) (39) (20) Net income from continuing operations, excluding special items $ 209 $ 132 $ 389 $ 437 Segment Information (unaudited) The following table presents selected segment financial information (in millions, except shipments which are inkilotonnes). Selected Operating Results Three Months Ended December31, 2020 North America Europe Asia South America Eliminationsand Other Total Adjusted EBITDA $ 206 $ 98 $ 78 $ 129 $ (10) $ 501 Shipments (in kt) Rolled products - third party 347 245 183 158 933 Rolled products - intersegment 8 1 (9) Total rolled products 347 253 184 158 (9) 933 Selected Operating Results Three Months Ended December31, 2019 North America Europe Asia South America Eliminationsand Other Total Adjusted EBITDA $ 127 $ 47 $ 55 $ 116 $ (2) $ 343 Shipments (in kt) Rolled products - third party 269 218 170 140 797 Rolled products - intersegment 6 3 6 (15) Total rolled products 269 224 173 146 (15) 797 Selected Operating Results Nine Months Ended December31, 2020 North America Europe Asia South America Eliminationsand Other Total Adjusted EBITDA $ 489 $ 181 $ 227 $ 317 $ (5) $ 1,209 Shipments (in kt) Rolled products - third party 986 685 541 418 2,630 Rolled products - intersegment 20 5 1 (26) Total rolled products 986 705 546 419 (26) 2,630 Selected Operating Results Nine Months Ended December31, 2019 North America Europe Asia South America Eliminations and Other Total Adjusted EBITDA $ 468 $ 160 $ 154 $ 309 $ (2) $ 1,089 Shipments (in kt) Rolled products - third party 844 678 529 411 2,462 Rolled products - intersegment 25 5 15 (45) Total rolled products 844 703 534 426 (45) 2,462 SOURCE Novelis Inc. Related Links http://www.novelis.com

Novelis Reports Third Quarter Fiscal 2021 Results Achieved record financials as a result of expanded business post-acquisition and outstanding operational performance to meet robust demand for innovative, sustainable aluminum solutions

NEW YORK, Feb. 19, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-00777, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired bluebird securities between May 11, 2020 and November 4, 2020, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. If you are a shareholder who purchased bluebird securities during the Class Period, you have until April 13, 2021to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com.To discuss this action, contact Robert S. Willoughby at [emailprotected]or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] bluebird is a biotechnology company that engages in researching, developing, and commercializing transformative gene therapies for severe genetic diseases and cancer. The Company's gene therapy programs include, among others, LentiGlobin (bb1111) for the treatment of sickle cell disease ("SCD"). In May 2020, in the midst of the COVID-19 pandemic, bluebird announced that the Company expected to submit a U.S. Biologics Licensing Application ("BLA") to the U.S. Food and Drug Administration ("FDA") for LentiGlobin for SCD in the second half of 2021. Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) data supporting bluebird's BLA submission for LentiGlobin for SCD was insufficient to demonstrate drug product comparability; (ii) Defendants downplayed the foreseeable impact of disruptions related to the COVID-19 pandemic on the Company's BLA submission schedule for LentiGlobin for SCD, particularly with respect to manufacturing; (iii) as a result of all the foregoing, it was foreseeable that the Company would not submit the BLA for LentiGlobin for SCD in the second half of 2021; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times. On November 4, 2020, post-market, bluebird disclosed that it would no longer apply for FDA approval of its LentiGlobin product as a treatment for SCD in the second half of 2021 as expected. Instead, citing "feedback" from the FDA requiring the Company to provide additional data "to demonstrate drug product comparability" for LentiGlobin for SCD, "alongside COVID-19 related shifts and contract manufacturing organization COVID-19 impacts," bluebird adjusted its submission timing to late 2022. On this news, bluebird's stock price fell $9.72 per share, or 16.6%, to close at $48.83 per share on November 5, 2020. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com CONTACT:Robert S. WilloughbyPomerantz LLP[emailprotected]888-476-6529 ext. 7980 SOURCE Pomerantz LLP Related Links www.pomerantzlaw.com

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE

DUBLIN--(BUSINESS WIRE)--The "Kick Boxing Equipment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 6th edition of this report. The 202-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Kick Boxing Equipment Market to Reach $219.4 Million by 2027 Amid the COVID-19 crisis, the global market for Kick Boxing Equipment estimated at US$174.5 Million in the year 2020, is projected to reach a revised size of US$219.4 Million by 2027, growing at a CAGR of 3.3% over the analysis period 2020-2027. Gloves, one of the segments analyzed in the report, is projected to record a 2.8% CAGR and reach US$49.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ankle/Knee/Elbow Guard segment is readjusted to a revised 3.8% CAGR for the next 7-year period. The U.S. Market is Estimated at $47.2 Million, While China is Forecast to Grow at 5.2% CAGR The Kick Boxing Equipment market in the U.S. is estimated at US$47.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$42.5 Million by the year 2027 trailing a CAGR of 5.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 2.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR. Punching Bags Segment to Record 4.2% CAGR In the global Punching Bags segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$18.5 Million in the year 2020 will reach a projected size of US$24.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$28.4 Million by the year 2027, while Latin America will expand at a 4.5% CAGR through the analysis period. Competitors identified in this market include, among others: Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITION For more information about this report visit https://www.researchandmarkets.com/r/ol4nnt

Insights on the Kick Boxing Equipment Global Market to 2027 - Featuring Adidas, Century and Everlast Worldwide Among Others - ResearchAndMarkets.com

CHICAGO, Aug. 26, 2020 /PRNewswire/ -- The global plant-based meat market size is expected to grow at a CAGR of over 18% during the period 20192025. Key Highlights Offered in the Report: Asia is expected to become of the most lucrative market for plant-based pork and accounted for over 15% of the market, where the African Swine Fever has reported to disrupt the pork supply. In North America, the plant-based chicken is expected to witness the fastest growth, followed by plant-based fish which is expected to grow at a CAGR of over 20% during the forecast period. In Europe, soy accounted for the largest share in the market as a plant-based meat protein source in 2019. However, pea which accounted for the second-largest share in the market is expected to witness the fastest growth and is expected to grow at a CAGR of over 18% during the forecast period. Soy is the most common protein source used in plant-based meat production. However, pea is increasingly becoming the key ingredient and is expected to generate an incremental revenue of over $1 billion by 2025. Although plant-based beef dominates the global market, plant-based chicken is likely to witness the fastest growth in the market at a CAGR of over 20% during the forecast period. The shift towards environmental sustainability, health awareness, and veganism is driving the market for plant-based meat alternatives. Key Offerings: Market Size & Forecast by Revenue | 20192025 Market Dynamics Leading trends, growth drivers, restraints, and investment opportunities Market Segmentation A detailed analysis by source, meat type, storage, distribution, and geography Competitive Landscape 21 key vendors are profiled Get your sample today! https://www.arizton.com/market-reports/plant-based-meat-market-size-analysis Plant-Based Meat Market Segmentation Wheat has been a traditional protein source in plant-based meat. The demand for wheat protein products has been declining considerably, owing to the growing incidence of gluten allergies. The rising health consciousness among consumers is also boosting the demand for gluten-free products. Increased efforts to enhance consumer awareness of the environmental impact of beef consumption is driving consumers to opt for sustainable substitutes. Beef substitutes are expected to continue to drive market growth in the future. Plant-based beef is still a niche segment in the global plant-based meat market and has enormous growth opportunities in the recent future, with growing penetration and demand for plant-based substitutes. As meat consumption is decreasing, the demand for an alternative product among non-vegan consumers. The positioning of vegan meat in the chilled meat department is expected to witness significant growth in demand. Moreover, Generation Z and millennial consumers are particularly perceiving chilled foods as more premium and fresher than frozen food, which is expected to boost the refrigerated meat market growth. Plant-Based Meat Market by Source Soy Pea Wheat Others Plant-Based Meat Market by Meat Type Beef Chicken Pork Fish Others Plant-Based Meat Market by Storage Frozen Refrigerated Shelf-stable Plant-Based Meat Market by Distribution Supermarkets & Hypermarkets Convenience Stores Specialty Stores Online Stores Others Plant-Based Meat Market Dynamics As the demand for vegan food rises at a precedented rate, the demand for clean labeled food products is also rising substantially. Veganism or vegan diet is often associated with healthy, wholesome, and natural products. Consumers are not only eating plant-based products but also seek whole foods that are free from artificial ingredients and additives. Most vegan foods, such as fruits and vegetables, nuts, grains, and oil, fall under the category of clean-label products. However, some processed vegan food options contain additives and ingredients that consumers seek to avoid. Clean label has moved from fad to mainstream, and several large and small brands are addressing the growing desire by reformulating ingredients of concern while ensuring that the ingredients are not only preferred by consumers but also function well in the finished product. Key Drivers and Trends fueling Market Growth: Growing Investment in Plant-Based Food Market Growth in Technology & Innovation Growth of Vegan Population Growing Concerns Regarding Environmental Sustainability Plant-Based Meat Market Geography The changing consumption patterns, emerging flexitarian, and vegan diets, rising environmental concerns, growing demand for better-for-you products in North America are driving the market for plant-based meat market in the region. The US is the largest market for plant-based meat globally. Due to the rising awareness of the benefits of plant-based protein and government initiatives, the plant-based protein market is expected to witness rapid growth in Canada. Many consumers avoid animal-sourced protein, thus broadening the opportunity to shift focus to producing alternate types of food that emerges, which drives the demand for plant-based meat. Get your sample today! https://www.arizton.com/market-reports/plant-based-meat-market-size-analysis Plant-Based Meat Market byGeography North America US Canada Europe UK Germany France Spain Italy APAC China Japan Australia Latin America Brazil Mexico Middle East & Africa Saudi Arabia UAE Prominent Vendors Beyond Meat Morningstar Farms Gardein Field Roast Turtle Island Food Impossible Foods Pure Farmland Sweet Earth Happy Little Plants Good Catch Tyson Foods Hungry Planet Next Level Burger Abbot's Butcher Atlantic Natural Foods Don Lee Farms Dr. Prager's Sensible Foods No Evil Foods Ocean Hugger Foods Sophie's Kitchen VBites Food Limited Explore our consumer goods & retail technology profileto know more about the industry. Read some of the top-selling reports: Plant Protein Market - Global Outlook and Forecast 2020-2025 Plant-based Cheese Market - Global Outlook and Forecast 2019-2024 U.S. Plant-based Meat Market - Industry Outlook and Forecast 2019-2024 Non-Dairy Milk Market - Global Outlook and Forecast 2019-2024 About Arizton: AriztonAdvisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services. We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. Mail: [emailprotected] Call: +1-312-235-2040+1-302-469-0707 SOURCE Arizton Advisory & Intelligence

Plant-Based Meat Market Size to Reach Revenues of over $12 Billion by 2025 - Arizton In-depth analysis and data-driven insights on the impact of COVID-19 included in this global plant-based meat market report

PITTSBURGH, June 29, 2020 /PRNewswire/ --While automotive manufacturers prioritize comfort for consumers, commercial trucks and passenger cars can become uncomfortable on long rides and are not equipped to fulfill the need for bathroom facilities in an emergency. Fortunately, an inventor from Los Angeles, Calif., has come up with a backup plan for such situations. He developed TRUCKERS COMFORT KIT to relieve pressure on the tailbone while sitting in a truck or car to help reduce the chances of developing hemorrhoids. At the same time, it provides a discreet way to relieve oneself in a motor vehicle when no rest room is available. By keeping toilet facilities readily accessible on the road, it enhances comfort for truckers and other travelers for overall good health. Users will also appreciate how convenient, effective and affordably priced it is. In addition, this lightweight, portable accessory is also easy to transport and use. The inventor's professional experience inspired the idea. "Sitting for extended periods of time as a long distance trucker, I found the seat so uncomfortable that I was concerned about getting hemorrhoids," he said. "Also, on these trips it was difficult to find a bathroom when I needed one and thought a portable unit would address both issues." The original design was submitted to the Los Angeles sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 18-LST-1027, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com

InventHelp Inventor Develops Personal Care Set for Use in a Motor Vehicle (LST-1027)

ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--Technology Innovation Institute (TII), the applied research pillar of Abu Dhabis Advanced Technology Research Council (ATRC), today announced the appointment of international experts in the field of systems security to the Board of Advisors of its Secure Systems Research Centre (SSRC). Secure Systems Research Centre is one of the initial seven dedicated centres at TII and is among the few global centres of its kind to bring together experts to conduct groundbreaking research in the field of secure systems. The distinguished new Board have combined expertise in security and resilience relating to autonomous computing and will guide the efforts of the Centres research team in developing end-to-end solutions to protect cyber-physical and autonomous systems. The Board of Advisors comprises: Prof. Ernesto Damiani, Professor, Department of Electrical Engineering and Computer Science, Senior Director, Artificial Intelligence & Intelligent Systems Institute, Director of the Center for Cyber Physical Systems (C2PS), Khalifa University in the UAE, whose research interests include secure service-oriented architectures, privacy-preserving big data analytics and cyber-physical systems security. Dr Hoda Alkhzaimi, Research Assistant Professor at New York University Abu Dhabi (NYUAD) and Director of the Universitys Center of Cyber Security, who was associated with research and development posts in cybersecurity and cryptology. Her research interests include unmanned aerial vehicle (UAV) security, cryptology, cryptanalysis, and building security hardware and software components. Dr Bushra Alblooshi, Head of Research and Innovation at Dubai Electronic Security Center (DESC), who is focused on researching cloud computing, cybersecurity, computer forensics and cryptography. Prof. Inseok Hwang, Professor at the School of Aeronautics and Astronautics at Purdue University, who specialises in research on intelligent and high assurance autonomy for cyber-physical systems with applications to complex networked systems, such as multi-vehicle systems. Prof. Dongyan Xu, Samuel D. Conte Professor of Computer Science at Purdue University, specialises in research focused on cyber and cyber-physical security. Prof. Taesoo Kim is Associate Professor at the School of Computer Science at the Georgia Institute of Technology, and his research interests span systems security architecture and design, threat intelligence, internet infrastructure and operating systems, machine learning, and programming languages. Prof. Wenke Lee is Professor of Computer Science and John P. Imlay Jr. Chair, College of Computing at the Georgia Institute of Technology, and is one of the most prolific and influential cybersecurity researchers in the world. His research specialty is systems and network security, applied cryptography and machine learning. Dr Harry Edelman is CEO of architectural consultancy Edelman Group and co-founder of AIDOMUS, a machine learning and IoT-based startup initiative for smart urban services. His work has focused on various aspects of integrated urban developments, including smart urban energy design and mobility. Dr Shreekant (Ticky) Thakkar, Chief Researcher at Secure Systems Research Centre, said: The Centre combines fundamental and applied research to set new standards and act as a catalyst to transform problems into solutions. The goal of the research team is to create new technologies for the development of end-to-end security and resilience in cyber-physical and autonomous systems. Research in security and resilience in cyber-physical and autonomous systems will ultimately lead to groundbreaking efforts in ensuring the safety and economic prosperity of our communities. The Board of Advisors will guide the expert SSRC researchers in carrying out such cutting-edge research while also creating new opportunities to train aspiring young UAE nationals in these significant fields. For more information about Secure Systems Research Centre (SSRC), visit tii.ae/securesystems *Source: AETOSWire

Abu Dhabis Technology Innovation Institute Appoints International Experts to Board of Advisors at Secure Systems Research Centre

LOS ANGELES, July 30, 2020 /PRNewswire/ -- elbow fans will be able to own the band's first three studio albums on vinyl when they are reissued on September 25, 2020. The heavyweight vinyl pressings cover debut, 'Asleep in the Back,' follow up 'Cast of Thousands' and third album, 'Leaders of the Free World.' In addition, the band's B sides collection 'Dead in the Boot' and 2014's 'The Take Off and Landing of Everything' will be repressed and restocked to stores, meaning that the entire elbow album catalog will now be available on vinyl. elbow fans will be able to own the bands first three studio albums on vinyl when they are reissued on September 25, 2020. The heavyweight vinyl pressings cover debut, Asleep in the Back, follow up Cast of Thousands and third album, Leaders of the Free World. In addition, the bands B sides collection Dead in the Boot and 2014s The Take Off and Landing of Everything will be repressed and restocked to stores, meaning that the entire elbow album catalog will now be available on vinyl. 'Asleep in the Back' was the album that introduced elbow to the world. Produced by Ben Hillier (Blur, Doves, Depeche Mode) and containing the singles; 'Newborn,' 'Any Day Now,' 'Red' and 'Powder Blue,' it established the band with the UK public and led to Mercury Award and Brit Award nominations. The album closes with perennial fan favorite 'Scattered Black and Whites,' recently revisited by the band in lockdown for their elbowrooms sessions. 'Cast of Thousands,' recorded at legendary Liverpool's legendary Parr Street Studios, with Ben Hiller again at the helm, introduced cover stars Elle and Bo to the world, their life size statues causing traffic jams when sited next to the motorway during festival dates to promote the album. Taking its title from the vocal contributions of the Glastonbury crowd to 'Grace Under Pressure,' recorded in a landmark performance on The Other Stage in 2002, the album artwork features the names of all those who contacted the band to say, 'yes, I was there and singing.' An early indicator of elbow's power to produce inclusive, uplifting moments, 'Cast of Thousands' also features 'Fugitive Motel' another track featured during the recent elbowrooms recordings. 'Leaders of the Free World' was the first album to be recorded at elbow's current home, Blueprint Studios, Manchester, and was co-produced by the band and Tom Rothrock, (Beck, Foo Fighters) and mixed at LA's legendary Sunset Sound Studios. Accompanied by full-length film from collaborators Soup Collective on its release, the album contains several tracks that grace elbow sets to this day including 'Great Expectations' and 'Station Approach.' All three albums were awarded 9/10 by the NME, marking the beginnings of a record run of consecutive 9/10 album reviews in the title that persisted through 'The Seldom Seen Kid' and 'build a rocket boys!' and all have surpassed gold status in the UK with 'The Seldom Seen Kid' achieving quadruple platinum status. 'Asleep in the Back,' 'Cast of Thousands' and 'Leaders of the Free World' vinyl editions will be available on September 25 from Polydor Records.www.elbow.co.ukSOURCE Polydor/UMe

elbow: First three albums reissued on vinyl on 9.25.20

CHARLESTON, S.C., Oct. 15, 2020 /PRNewswire/ --To the excitement of new parents everywhere,Nanobebeis expanding their lineup ofinnovativebaby care essentialswith the introduction of the Flexy Silicone Baby Bottle.The newadditionaccompanies the brand's award-winning Breastmilk Bottletoprovidethe complete bottle-feeding solutionfornewborns through early toddlerhood,whether fed breast milk or formula. Continue Reading With the launch of the brand new Flexy Silicone Baby Bottle, Nanobebe provides the perfect bottle options, whether parents are feeding their little ones breast milk or formula. Silicone baby bottles are in high demand for their multitude of benefits, but the assortment available to new parents hadsignificantpain points.Nanobebestudied every critique of the current contenders on the market and meticulously designed features that solve each issue. These advancements include mom-like softness, a stable base that won't tip over, and a non-collapsible nipple for the perfect latch parents can trust. Its genius anti-colic system is the first of its kind with a 360 triple vented design. "Our team's commitment to the health of our next generation drives the design of everyNanobebeproduct by identifying the day-to-day challenges of modern parenting and finding real solutions that work. Our new Flexy Silicone Bottle does just that, and there's more to come." - AsafKehatand AyalLanternari, co-founders From the first nutrient-preserving breastmilk bottle to the most advanced silicone baby bottle on the market,Nanobebeprovides specialized, health-focused options for every little one's feeding journey. Now a one-stop-shop for all things feeding,Nanobebeis leading in innovation and revolutionizing convenience for the modern parent.AboutNanobebeDedicated first and foremost to babies' health,Nanobebejoined forces with a team of pediatricians, lactation consultants, and biomedical engineers with a vision to be the first choice in baby care. Their team continuously designs new technology in baby care that supports the special bonding momentsfeedingtimecreates between parents and their little ones.The product line includes the first-ever nutrient-preserving baby bottles, the most advanced silicone baby bottles on the market, eye-catching travel essentials, innovative breastmilk storage, 100% silicone pacifiers, and more. The sleek and modern ecosystem is a complete game-changer with designs that make nutritional feeding and travel with little ones an absolute breeze, without sacrificing on style and convenience.Media Contact:Mary Williams, [emailprotected]Related Imagesthe-complete-baby-feeding-solution.jpg The Complete Baby Feeding Solution With the launch of the brand new Flexy Silicone Baby Bottle, Nanobebe provides the perfect bottle options, whether parents are feeding their little ones breast milk or formula. Related LinksAdd to Babylist Baby Registry Shop on Amazon Related Videohttp://www.youtube.com/watch?v=6k0HBrlzlbY SOURCE Nanobebe

Nanobebe Launches the Most Advanced Silicone Baby Bottle The globally adored baby brand now offers a complete feeding solution with the debut of their newest innovation

DUBLIN, Nov. 20, 2020 /PRNewswire/ -- The "Plastic Caps and Closures Market by Product Type (Screw-on Caps, Dispensing Caps), Technology (Injection Molding, Compression Molding, Post-mold TE Band), Raw Material (PP, HDPE, LDPE), End-use (Beverage, Pharmaceutical), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The plastic caps & closures market was USD 42.33 billion in 2019 and is projected to reach USD 57.03 billion by 2025, at a CAGR of 5.18% between 2020 and 2025. Increase in demand for bottled water, need for convenience, concerns about product safety & security, product differentiation & branding, and decreasing package sizes are driving the market for plastic caps & closures. However, the development of substitutes is expected to restrain this market. Emerging economies are expected to offer significant growth opportunities to manufacturers of plastic caps & closures. The major challenge faced by players is the mature market in developed regions.The screw-on caps segment is expected to grow at the highest CAGR during the forecast period in the plastic caps & closures market.The screw-on caps segment accounted for the largest share and is projected to grow at the highest CAGR during the forecast period. This is attributed to its wide application in various end-use industries such as beverage, pharmaceutical, and personal care. Moreover, they are cost-effective and lightweight.A plastic screw closure is a well-engineered product that is screwed on and off on a container. These closures contain either continuous threads or lugs. It must be engineered and designed to be cost-effective, compatible with contents, easy to open; provide an effective seal; and comply with the product, package, and environmental laws and regulations.The post-mold TE band segment is expected to be the fastest-growing technology during the forecast period in the plastic caps & closures marketIn terms of both value and volume, the post-mold TE band segment accounted for the largest shares, and it is also projected to grow at the highest CAGR. In the post-mold technology, slitting is a secondary operation to achieve tamper-evident plastic caps & closures. This post-mold technology is comparatively economical and time-effective.The plastic segment is expected to be the fastest-growing container type during the forecast period in the plastic caps & closures marketIn terms of value and volume, the plastic segment accounted for the largest share in 2019 and is projected to grow at a comparatively higher CAGR during the forecast period. Plastic containers are economical and lightweight. They are primarily used for packaging CSDs and bottled water owing to cost-effectiveness.The PP segment is expected to lead and be the fastest-growing raw material during the forecast period in the plastic caps & closures marketThe PP segment leads the market. PP is widely used owing to its high resistance to chemical corrosion property, making it an excellent choice for packaging for cleaning products, bleaches, and first-aid products, among others. It also offers excellent fatigue resistance and elasticity, securing it a well-deserved reputation for toughness and durability.The beverage segment is expected to account for the largest share in the plastic caps & closures marketBeverage packaging is the largest end-use sector of plastic caps & closures. Beverage packaging is used to enhance the shelf life as well as to retain the taste and texture of the beverage. The demand from beverage companies for novel differentiating closures drives the market for premium caps in the beverages industry. Plastic caps & closures have witnessed extensive traction for the packaging of bottled water, carbonated soda drinks, and non-carbonated soda drinks.North America is expected to be the largest plastic caps & closures market during the forecast period, in terms of volume.The US, Canada, and Mexico are the major countries contributing to the plastic caps & closures market in North America. The growth is driven by factors such as the rise in demand for single-portion packs or small packs, increased demand for convenience food, concerns about product safety & security, and need for product differentiation and branding. The presence of major plastic caps & closures manufacturers has also contributed to the growth of the plastic caps & closures market in this region.Key Topics Covered: 1 Introduction 2 Research Methodology3 Executive Summary4 Premium Insights4.1 Attractive Opportunities in the Plastic Caps & Closures Market4.2 Plastic Caps & Closures Market, by Product Type4.3 Plastic Caps & Closures Market, by Technology4.4 Plastic Caps & Closures Market, by Container Type4.5 Plastic Caps & Closures Market, by Raw Material4.6 Plastic Caps & Closures Market, by End-Use Sector4.7 Plastic Caps & Closures Market, by Country4.8 APAC: Plastic Caps & Closures Market4.9 Plastic Caps & Closures Market: Regional Snapshot5 Market Overview5.1 Introduction5.2 Value Chain Analysis5.3 Market Dynamics5.3.1 Drivers5.3.1.1 Increase in Demand for Bottled Water5.3.1.2 Need for Convenience and Concerns About Product Safety & Security5.3.1.3 Product Differentiation & Branding and Decreasing Package Sizes5.3.2 Restraints5.3.2.1 Development of Substitutes5.3.3 Opportunities5.3.3.1 Emerging Economies5.3.4 Challenges5.3.4.1 Mature Markets in Developed Regions5.4 Porter's Five Forces Analysis5.4.1 Threat of New Entrants5.4.2 Threat of Substitutes5.4.3 Bargaining Power of Suppliers5.4.4 Bargaining Power of Buyers5.4.5 Intensity of Competitive Rivalry5.5 COVID-19 Impact on Plastic Caps & Closures Market5.5.1 Impact of COVID-19 on Plastic Packaging5.5.2 Impact of COVID-19 on End-Use Sectors for Plastic Caps & Closures 625.5.2.1 Impact of COVID-19 on Food & Beverage Industry5.5.2.2 Impact of COVID-19 on Pharmaceutical Industry5.5.2.3 Impact of COVID-19 on Personal & Homecare Industry5.5.3 Impact of COVID-19 on Various Countries6 Plastic Caps & Closures Market, by Product Type6.1 Introduction6.2 Screw-On Caps6.3 Dispensing Caps6.4 Others7 Plastic Caps & Closures Market, by Container Type7.1 Introduction7.2 Plastic7.3 Glass8 Plastic Caps & Closures Market, by Technology8.1 Introduction8.2 Post-Mold Tamper-Evident (Te8.3 Compression Molding8.4 Injection Molding9 Plastic Caps & Closures Market, by Raw Material9.1 Introduction9.2 Pp (Polypropylene9.3 Hdpe (High-Density Polyethylene9.4 Ldpe (Low-Density Polyethylene9.5 Others10 Plastic Caps & Closures Market, by End-Use Sector10.1 Introduction10.2 Beverage10.3 Food10.4 Pharmaceutical10.5 Personal & Homecare10.6 Others11 Plastic Caps & Closures Market, by Region11.1 Introduction11.2 APAC11.3 Europe11.4 North America11.5 Middle East & Africa11.6 South America12 Competitive Landscape12.1 Introduction12.2 Competitive Leadership Mapping12.2.1 Star12.2.2 Emerging Leaders12.2.3 Pervasive12.2.4 Emerging Companies12.3 Strength of Product Portfolio12.4 Business Strategy Excellence12.5 Market Ranking of Key Players12.6 Competitive Scenario12.6.1 Expansions & Investments12.6.2 Mergers & Acquisitions12.6.3 Contracts & Agreements, Joint Ventures & Partnerships, and Collaborations 16512.6.4 New Product Launches/Development13 Company Profiles13.1 Berry Global Group, Inc.13.2 Amcor plc13.3 Crown Holdings, Inc.13.4 Silgan Holdings13.5 Bericap13.6 Aptargroup13.7 Coral Products13.8 O.Berk Company, LLC13.9 Guala Closures S.P.A13.10 Additional Companies13.10.1 United Caps13.10.2 Caps & Closures Pty Ltd13.10.3 Caprite Australia Pty. Ltd13.10.4 Pano Cap (Canada13.10.5 Plastic Closures Limited13.10.6 Cap & Seal Pvt. Ltd13.10.7 Phoenix Closures13.10.8 Alupac India13.10.9 Hicap Closures13.10.10 Mjs Packaging13.10.11 J.L. Clark13.10.12 Trimas13.10.13 Comar, LLC14 Appendix For more information about this report visit https://www.researchandmarkets.com/r/iw828l Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Worldwide Industry for Plastic Caps and Closures to 2025 - Featuring Berry Global Group, Amcor & Crown Holdings Among Others

NEW YORK, June 12, 2020 /PRNewswire/ --Computer Numerical Controls Market Research Report by Machine (Grinding Machines, Laser Machines, Lathe Machines, Milling Machines, and Welding Machines), by End User (Aerospace & Defense, Automotive, Construction Equipment, Consumer Goods, and Industrial) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Read the full report: https://www.reportlinker.com/p05913925/?utm_source=PRN The Global Computer Numerical Controls Market is expected to grow from USD 15,154.29 Million in 2019 to USD 30,578.52 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.41%.Market Segmentation & Coverage:This research report categorizes the Computer Numerical Controls to forecast the revenues and analyze the trends in each of the following sub-markets:On the basis of Machine, the Computer Numerical Controls Market is studied across Grinding Machines, Laser Machines, Lathe Machines, Milling Machines, Welding Machines, and Winding Machines. On the basis of End User, the Computer Numerical Controls Market is studied across Aerospace & Defense, Automotive, Construction Equipment, Consumer Goods, Industrial, Metal & Mining, Power & Energy, and Transportation. On the basis of Geography, the Computer Numerical Controls Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Computer Numerical Controls Market including Amada Co., Ltd., Amera Seiki, Dmtg Corporation, Fanuc Corporation, Haas Automation, Hurco Companies, Inc., Hurco Companies, Inc., Okuma Corporation, Shenyang Machine Tool Co., Ltd., and Yamazaki Mazak Corporation. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Computer Numerical Controls Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Computer Numerical Controls Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Computer Numerical Controls Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Computer Numerical Controls Market?4. What is the competitive strategic window for opportunities in the Global Computer Numerical Controls Market?5. What are the technology trends and regulatory frameworks in the Global Computer Numerical Controls Market?6. What are the modes and strategic moves considered suitable for entering the Global Computer Numerical Controls Market?Read the full report: https://www.reportlinker.com/p05913925/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com

The Global Computer Numerical Controls Market is expected to grow from USD 15,154.29 Million in 2019 to USD 30,578.52 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.41%

MT. LAUREL, N.J., March 19, 2021 /PRNewswire/ --Pinnacle Treatment Centers, a leader in providing accessible, affordable treatment for individuals struggling with substance abuse, has opened Athens Treatment Services, Hamilton Treatment Services and Solon Treatment Services in Ohio. Athens Treatment Servicesis located at 8978 United Lane, Suite 102, in Athens; Hamilton Treatment Services is located in 8500 Bilstein Blvd in Hamilton; and Solon Treatment Services is located at 29201 Aurora Road, Suite 500, in Solon. The community-based programs are among Pinnacle's 19 outpatient opioid addiction treatment centers in the Buckeye State with more on the way. In addition, Pinnacle operates a detox unitRecovery Works Portagein Ravenna; a residential treatment centerRecovery Worksin Columbus; and intensive outpatient programs with recovery homes, also in Columbus. 2020 proved to be a devastating year, not just because of COVID deaths, but because of the overdose deaths that also resulted from the coronavirus pandemic. A news release issued by the office of the Ohio Attorney General David Yost in January stated that more Ohioans died of an opioid overdose during a three-month period last year than at any time since the opioid epidemic began. Athens, Butler, and Cuyahoga Counties are three of the many areas that have seen an increase in drug-related deaths and continue to be afflicted by opioid abuse. "Ohio needs more treatment. We're trying to meet that need as quickly as possible with quality, affordable care," said Joe Pritchard, CEO, Pinnacle Treatment Centers, which offers a full continuum of care throughout Ohio. A U.S. Navy veteran, Pritchard went through his own recovery journey more than 45 years ago and has made it his personal mission to help others overcome the disease of addiction. "Addiction can affect anyone, your neighbor, your friend, your co-worker, your loved one. And this is how we can be impactful, by being embedded in the communities that need help the most." Medicaid-friendly, all three centers provide medication-assisted treatment (MAT), particularly methadone, at the facilities. MAT is the gold standard of care for opioid addiction and includes methadone, buprenorphine, Vivitrol, and counseling. The FDA-approved medicines work to curb withdrawal symptoms from heroin and pain pill addiction; prevent relapse; and help ease the physical discomfort that accompanies opioid recovery. Individual and group counseling is provided as part of a holistic approach to patient care. Relapse prevention, nutrition education, life skills counseling, meditation strategies, and trigger identification and management are a few areas of focus. Holly Broce, president of Pinnacle's opioid treatment program division, said, "It's been a painful year for so many individuals. Unfortunately, many have turned to drugs and alcohol to cope. Overdoses have spiked almost everywhere, but it's important to remember, any amount of overdoses is too many." The ultimate goal of MAT is full recovery, including the ability to live a self-directed life. This treatment approach has been shown to improve patient survival; increase retention in treatment; decrease illicit opioid use and other criminal activity; increase patients' ability to gain and maintain employment; and more. All three centers accept Medicaid, commercial insurance, and offer reasonable self-pay rates. Their hours are Mondays through Fridays, 6 a.m.- 2 p.m., and on Saturdays, 6 a.m.- 9 a.m. Individuals can call Athens at 740-274-4246; Hamilton at 513-285-9583; and Solon at 440-337-4349 for a free confidential assessment. About Pinnacle Treatment Centers Headquartered in New Jersey, Pinnacle Treatment Centers is a recognized leader in comprehensive drug and alcohol addiction treatment serving nearly 33,000 patients daily in California (Aegis Treatment Centers), Georgia (HealthQwest), Indiana, Kentucky, New Jersey, Ohio, Pennsylvania, and Virginia. With more than 115 community-based locations, Pinnacle provides a full continuum of quality care including medically-monitored detoxification/withdrawal management, residential treatment, partial hospitalization and intensive outpatient programming with recovery homes, and outpatient medication-assisted treatment (MAT) for opioid use disorder. For more information, visit pinnacletreatment.com or call 800-782-1520. SOURCE Pinnacle Treatment Centers Related Links https://pinnacletreatment.com/contact/

Pinnacle Treatment Centers Opens Three Additional Opioid Addiction Treatment Centers In Ohio Athens Treatment Services, Hamilton Treatment Services and Solon Treatment Services part of Pinnacle's expansion in the fight against the opioid crisis

GTEBORG, Sweden, June 22, 2020 /PRNewswire/ --Following up on Stena Bulk's successful biofuel trial in April, the company is now introducing low-carbon shipping options for its customers. Biofuel has the potential of putting shipping on the trajectory towards IMO's greenhouse gas reduction targets, without having to wait for new technology and zero-carbon fuels to emerge as commercially viable options.Our recent trial, where a cross-Atlantic voyage was conducted with 100% waste-based biofuel, proved the technical and operational feasibility of using biofuels in regular tanker operations, and Stena Bulk is now taking it one step further by introducing a set of low-carbon shipping options for its customers. The options will range from 20% to 100% biofuels and will be based on an offsetting program where the biofuel is used within the Stena Bulk fleet. This allows customers to make use of low-carbon shipping options regardless of fuel availability on the specific route. It also guarantees that operation is performed without any disturbance to the shipment."Performing according to our customers' expectations is our highest priority, and this setup allows us to continue to do that while also offering a service," says Erik Hnell, President and CEO for Stena Bulk. "It will be one way to take actions in meeting future requirements. This type of fuel is one step in many combined sustainable solutions that needs to be considered and can be used today." Offering low-carbon shipping options is initially an ambitious initiative, but is reflective of Stena Bulk's ambition to reduce the environmental footprint of tanker operations through innovation. New fuels and new technology like Stena Bulk's recently presented IMOFlexMAX vessel design will also be important in that we can test and learn through challenges and thus take further steps in developments for the future. Collaboration within the industry will also be a key element, and the company will continue to develop new solutions together with customers, partners and suppliers."We need to come together as an industry to find solutions that comply with future legislation," says Erik Hnell. "By working together, sharing experiences, risks and inspiring each other, we are convinced that we will meet the targets and ensure that shipping remains the most efficient and sustainable mode of transportation."Stena Bulk MR vesselStena Immortalran on 100% biofuel during a 10-day sea trial.https://youtu.be/r5ARF2aEDdgAbout Stena BulkWith offices in seven countries,Stena Bulkis one of the world's leading tanker shipping companies. The company controls a combined fleet of around 115 tankers. Stena Bulk is part of the Stena Sphere, which has more than 20,000 employees and annual sales of USD 8 billion.www.stenabulk.com For more information, please contact:Erik HnellPresident & CEOMobile +46-704-855-002[emailprotected] This information was brought to you by Cision http://news.cision.com https://news.cision.com/stena-bulk/r/stena-bulk-to-introduce-low-carbon-shipping-options,c3138991 The following files are available for download: https://mb.cision.com/Main/2249/3138991/1267775.pdf Release https://news.cision.com/stena-bulk/i/stena-immortal-biofuel-bunkering--,c2798779 Stena Immortal biofuel bunkering. https://news.cision.com/stena-bulk/i/stena-immortal-bunkering-biofuel--,c2798780 Stena Immortal bunkering biofuel. Captions for above Photos: 1. Stena Immortal biofuel bunkering 2. Stena Immortal bunkering biofuel SOURCE Stena Bulk

Stena Bulk to Introduce Low-carbon Shipping Options

DUBLIN, June 25, 2020 /PRNewswire/ -- The "Dry, Condensed, and Evaporated Dairy Product Global Market Report 2020-30: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering. The global dry, condensed, and evaporated dairy product market is expected to grow from $92.6 billion in 2019 to $94.1 billion in 2020 at a compound annual growth rate (CAGR) of 1.6%. The low growth is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 6% from 2021 and reach $111.6 billion in 2023.This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider dry, condensed, and evaporated dairy product market, and compares it with other markets.The demand for clean label products is increasing rapidly owing to a significant rise in awareness of healthy eating. Clean label dairy products do not contain additives, artificial flavor enhancers, dyes or artificial preservatives. Also, many food service and retail grocery store chains are stating lists of ingredients that cannot be present in food items in their stores or restaurants. According to a survey of 1,000 customers in the UK and Russia by Ingredion, 70% of consumers purchasing dairy and bakery products are aware of clean labels and the presence of clean labels influences their buying decisions and 30% of consumers are looking for some kind of clean label claim.Western Europe was the largest region in the global dry, condensed, and evaporated dairy product market, accounting for 32% of the market in 2019. Asia-Pacific was the second largest region accounting for 31% of the global dry, condensed, and evaporated dairy product market. Africa was the smallest region in the global dry, condensed, and evaporated dairy product market.Report Scope The market characteristics section of the report defines and explains the market. The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery. Market segmentations break down market into sub markets. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets. Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers. The dry, condensed, and evaporated dairy product market section of the report gives context. It compares the dry, condensed, and evaporated dairy product market with other segments of the dairy food market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, dry, condensed, and evaporated dairy product indicators comparison. Key Topics Covered 1. Executive Summary 2. Report Structure 3. Dry, Condensed, And Evaporated Dairy Product Market Characteristics 3.1. Market Definition 3.2. Key Segmentations 4. Dry, Condensed, And Evaporated Dairy Product Market Product Analysis 4.1. Leading Products/ Services 4.2. Key Features and Differentiators 4.3. Development Products 5. Dry, Condensed, And Evaporated Dairy Product Market Supply Chain 5.1. Supply Chain 5.2. Distribution 5.3. End Customers 6. Dry, Condensed, And Evaporated Dairy Product Market Customer Information 6.1. Customer Preferences 6.2. End Use Market Size and Growth 7. Dry, Condensed, And Evaporated Dairy Product Market Trends And Strategies 8. Dry, Condensed, And Evaporated Dairy Product Market Size And Growth 8.1. Market Size 8.2. Historic Market Growth, Value ($ Billion) 8.2.1. Drivers Of The Market 8.2.2. Restraints On The Market 8.3. Forecast Market Growth, Value ($ Billion) 8.3.1. Drivers Of The Market 8.3.2. Restraints On The Market 9. Dry, Condensed, And Evaporated Dairy Product Market Regional Analysis 9.1. Global Dry, Condensed, And Evaporated Dairy Product Market, 2019, By Region, Value ($ Billion) 9.2. Global Dry, Condensed, And Evaporated Dairy Product Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region 9.3. Global Dry, Condensed, And Evaporated Dairy Product Market, Growth And Market Share Comparison, By Region 10. Dry, Condensed, And Evaporated Dairy Product Market Segmentation 10.1. Global Dry, Condensed, And Evaporated Dairy Product Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion Dry Dairy Product Condensed Dairy Product Evaporated Dairy Product 10.2. Global Dry, Condensed, And Evaporated Dairy Product Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion Supermarkets/Hypermarkets Convenience Stores E-Commerce Others 10.3. Global Dry, Condensed, And Evaporated Dairy Product Market, Segmentation By End Use, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion Food Beverages Intermediate Products Condiments Other 11. Dry, Condensed, And Evaporated Dairy Product Market Metrics 11.1. Dry, Condensed, And Evaporated Dairy Product Market Size, Percentage Of GDP, 2015-2023, Global 11.2. Per Capita Average Dry, Condensed, And Evaporated Dairy Product Market Expenditure, 2015-2023, Global Companies Mentioned Nestle S.A. The J.M. Smucker Company GCMMF Pvt. Ltd. Magnolia Inc. Goya Foods Inc. For more information about this report visit https://www.researchandmarkets.com/r/h97hes Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

$111+ Billion Dry, Condensed & Evaporated Dairy Products Industry Assessment 2020-2023 and Beyond - COVID-19 Adjusted